(516758, 'HP:0031594', 'PR segment depression', 'MP:0031215', 'abnormal response to myocardial ischemic injury', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516759, 'HP:0031594', 'PR segment depression', 'MP:0020347', 'abnormal myocardial fiber sodium currents', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516760, 'HP:0031594', 'PR segment depression', 'MP:0003897', 'abnormal ST segment', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516761, 'HP:0031594', 'PR segment depression', 'MP:0010515', 'abnormal Q wave', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516762, 'HP:0031594', 'PR segment depression', 'MP:0000343', 'abnormal response to cardiac infarction', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516763, 'HP:0031594', 'PR segment depression', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516764, 'HP:0031594', 'PR segment depression', 'MP:0010520', 'sinoatrial block', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516765, 'HP:0031594', 'PR segment depression', 'MP:0006052', 'cerebellum hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516766, 'HP:0031594', 'PR segment depression', 'MP:0014275', 'increased respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516767, 'HP:0031594', 'PR segment depression', 'MP:0020001', 'decreased response to antigen', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516768, 'HP:0031594', 'PR segment depression', 'MP:0010393', 'shortened QRS complex duration', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516769, 'HP:0031594', 'PR segment depression', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516770, 'HP:0031594', 'PR segment depression', 'MP:0003477', 'abnormal nerve fiber response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516771, 'HP:0031594', 'PR segment depression', 'MP:0001864', 'vascular inflammation', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516772, 'HP:0031594', 'PR segment depression', 'MP:0003009', 'abnormal cytokine secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516773, 'HP:0031594', 'PR segment depression', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516774, 'HP:0031594', 'PR segment depression', 'MP:0003926', 'decreased cellular glucose uptake', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516775, 'HP:0031594', 'PR segment depression', 'MP:0004012', 'increased pulmonary artery pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516776, 'HP:0031594', 'PR segment depression', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516777, 'HP:0031594', 'PR segment depression', 'MP:0003866', 'abnormal defecation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516778, 'HP:0031594', 'PR segment depression', 'MP:0031009', 'abnormal sperm-egg fusion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516779, 'HP:0031594', 'PR segment depression', 'MP:0003674', 'oxidative stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516780, 'HP:0031594', 'PR segment depression', 'MP:0005671', 'abnormal response to transplant', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516781, 'HP:0031594', 'PR segment depression', 'MP:0011953', 'prolonged PQ interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516782, 'HP:0031594', 'PR segment depression', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516783, 'HP:0031594', 'PR segment depression', 'MP:0004009', 'abnormal diastolic filling velocity', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516784, 'HP:0031594', 'PR segment depression', 'MP:0009697', 'abnormal copulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516785, 'HP:0031594', 'PR segment depression', 'MP:0002634', 'abnormal sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516786, 'HP:0031594', 'PR segment depression', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516787, 'HP:0031594', 'PR segment depression', 'MP:0003548', 'pulmonary hypertension', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516788, 'HP:0031594', 'PR segment depression', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516789, 'HP:0031594', 'PR segment depression', 'MP:0002421', 'abnormal cell-mediated immunity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516790, 'HP:0031594', 'PR segment depression', 'MP:0004085', 'abnormal heartbeat', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516791, 'HP:0031594', 'PR segment depression', 'MP:0011046', 'abnormal lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516792, 'HP:0031594', 'PR segment depression', 'MP:0001919', 'abnormal reproductive system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516793, 'HP:0031594', 'PR segment depression', 'MP:0003260', 'vomiting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516794, 'HP:0031594', 'PR segment depression', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516795, 'HP:0031594', 'PR segment depression', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516796, 'HP:0031594', 'PR segment depression', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516797, 'HP:0031594', 'PR segment depression', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516798, 'HP:0031594', 'PR segment depression', 'MP:0020419', 'decreased cardiac muscle relaxation', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516799, 'HP:0031594', 'PR segment depression', 'MP:0009384', 'cardiac valve regurgitation', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516800, 'HP:0031594', 'PR segment depression', 'MP:0001663', 'abnormal digestive system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516801, 'HP:0031594', 'PR segment depression', 'MP:0004212', 'abnormal salty taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516802, 'HP:0031594', 'PR segment depression', 'MP:0001636', 'irregular heartbeat', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516803, 'HP:0031594', 'PR segment depression', 'MP:0011918', 'abnormal PQ interval', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516804, 'HP:0031594', 'PR segment depression', 'MP:0004752', 'decreased length of allograft survival', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516805, 'HP:0031594', 'PR segment depression', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516806, 'HP:0031594', 'PR segment depression', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516807, 'HP:0031594', 'PR segment depression', 'MP:0011931', 'abnormal pulmonary valve flow', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516808, 'HP:0031594', 'PR segment depression', 'MP:0004084', 'abnormal cardiac muscle relaxation', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516809, 'HP:0031594', 'PR segment depression', 'MP:0004875', 'increased mean systemic arterial blood pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516810, 'HP:0031594', 'PR segment depression', 'MP:0002499', 'chronic inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516811, 'HP:0031594', 'PR segment depression', 'MP:0005501', 'abnormal skin physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516812, 'HP:0031594', 'PR segment depression', 'MP:0013136', 'genital discharge', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516813, 'HP:0031594', 'PR segment depression', 'MP:0003077', 'abnormal cell cycle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516814, 'HP:0031594', 'PR segment depression', 'MP:0001761', 'abnormal urination pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516815, 'HP:0031594', 'PR segment depression', 'MP:0020381', 'muscle gating pore current', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516816, 'HP:0031594', 'PR segment depression', 'MP:0010553', 'prolonged HV interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516817, 'HP:0031594', 'PR segment depression', 'MP:0004036', 'abnormal muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516818, 'HP:0031594', 'PR segment depression', 'MP:0001983', 'abnormal olfactory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516819, 'HP:0031594', 'PR segment depression', 'MP:0003898', 'abnormal QRS complex', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516820, 'HP:0031594', 'PR segment depression', 'MP:0011390', 'abnormal fetal cardiomyocyte physiology', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516821, 'HP:0031594', 'PR segment depression', 'MP:0010512', 'absent PR interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516822, 'HP:0031594', 'PR segment depression', 'MP:0011045', 'decreased lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516823, 'HP:0031594', 'PR segment depression', 'MP:0003927', 'increased cellular glucose import', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516824, 'HP:0031594', 'PR segment depression', 'MP:0003547', 'abnormal pulmonary pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516825, 'HP:0031594', 'PR segment depression', 'MP:0004879', 'decreased systemic vascular resistance', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516826, 'HP:0031594', 'PR segment depression', 'MP:0030988', 'dysosmia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516827, 'HP:0031594', 'PR segment depression', 'MP:0003394', 'increased cardiac output', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516828, 'HP:0031594', 'PR segment depression', 'MP:0002161', 'abnormal fertility/fecundity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516829, 'HP:0031594', 'PR segment depression', 'MP:0010570', 'prolonged ST segment', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516830, 'HP:0031594', 'PR segment depression', 'MP:0003091', 'abnormal cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516831, 'HP:0031594', 'PR segment depression', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516832, 'HP:0031594', 'PR segment depression', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516833, 'HP:0031594', 'PR segment depression', 'MP:0003824', 'decreased left ventricle developed pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516834, 'HP:0031594', 'PR segment depression', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516835, 'HP:0031594', 'PR segment depression', 'MP:0010071', 'abnormal pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516836, 'HP:0031594', 'PR segment depression', 'MP:0012685', 'abnormal primitive streak elongation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516837, 'HP:0031594', 'PR segment depression', 'MP:0001921', 'reduced fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516838, 'HP:0031594', 'PR segment depression', 'MP:0031090', 'ageusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516839, 'HP:0031594', 'PR segment depression', 'MP:0020371', 'abnormal glymphatic system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516840, 'HP:0031594', 'PR segment depression', 'MP:0013639', 'decreased bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516841, 'HP:0031594', 'PR segment depression', 'MP:0004485', 'increased response of heart to induced stress', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516842, 'HP:0031594', 'PR segment depression', 'MP:0002322', 'abnormal respiratory transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516843, 'HP:0031594', 'PR segment depression', 'MP:0010753', 'improved mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516844, 'HP:0031594', 'PR segment depression', 'MP:0005001', 'abnormal clonal deletion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516845, 'HP:0031594', 'PR segment depression', 'MP:0003928', 'increased heart rate variability', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516846, 'HP:0031594', 'PR segment depression', 'MP:0004877', 'abnormal systemic vascular resistance', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516847, 'HP:0031594', 'PR segment depression', 'MP:0003621', 'dysuria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516848, 'HP:0031594', 'PR segment depression', 'MP:0010636', 'bundle branch block', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516849, 'HP:0031594', 'PR segment depression', 'MP:0011431', 'increased urine flow rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516850, 'HP:0031594', 'PR segment depression', 'MP:0010509', 'decreased P wave amplitude', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516851, 'HP:0031594', 'PR segment depression', 'MP:0020002', 'increased response to antigen', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516852, 'HP:0031594', 'PR segment depression', 'MP:0008004', 'abnormal stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516853, 'HP:0031594', 'PR segment depression', 'MP:0002842', 'increased systemic arterial blood pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516854, 'HP:0031594', 'PR segment depression', 'MP:0003925', 'abnormal cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516855, 'HP:0031594', 'PR segment depression', 'MP:0002635', 'reduced sensorimotor gating', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516856, 'HP:0031594', 'PR segment depression', 'MP:0003566', 'abnormal cell adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516857, 'HP:0031594', 'PR segment depression', 'MP:0003470', 'abnormal summary potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516858, 'HP:0031594', 'PR segment depression', 'MP:0010822', 'pneumothorax', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516859, 'HP:0031594', 'PR segment depression', 'MP:0002128', 'abnormal blood circulation', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516860, 'HP:0031594', 'PR segment depression', 'MP:0006143', 'increased systemic arterial diastolic blood pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516861, 'HP:0031594', 'PR segment depression', 'MP:0005600', 'increased ventricle muscle contractility', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516862, 'HP:0031594', 'PR segment depression', 'MP:0030214', 'muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516863, 'HP:0031594', 'PR segment depression', 'MP:0010554', 'shortened HV interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516864, 'HP:0031594', 'PR segment depression', 'MP:0003899', 'abnormal QT interval', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516865, 'HP:0031594', 'PR segment depression', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516866, 'HP:0031594', 'PR segment depression', 'MP:0021015', 'increased tau protein phosphorylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516867, 'HP:0031594', 'PR segment depression', 'MP:0010552', 'abnormal HV interval', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516868, 'HP:0031594', 'PR segment depression', 'MP:0006114', 'cardiac murmur', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516869, 'HP:0031594', 'PR segment depression', 'MP:0000233', 'abnormal blood flow velocity', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516870, 'HP:0031594', 'PR segment depression', 'MP:0031192', 'coronary artery spasm', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516871, 'HP:0031594', 'PR segment depression', 'MP:0001599', 'abnormal blood volume', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516872, 'HP:0031594', 'PR segment depression', 'MP:0008544', 'impaired olfaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516873, 'HP:0031594', 'PR segment depression', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516874, 'HP:0031594', 'PR segment depression', 'MP:0003042', 'decreased time of onset of induced ischemic contracture', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516875, 'HP:0031594', 'PR segment depression', 'MP:0009275', 'bruising', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516876, 'HP:0031594', 'PR segment depression', 'MP:0004122', 'abnormal sinus arrhythmia', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516877, 'HP:0031594', 'PR segment depression', 'MP:0006144', 'increased systemic arterial systolic blood pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516878, 'HP:0031594', 'PR segment depression', 'MP:0031136', 'muscle hemorrhage', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516879, 'HP:0031594', 'PR segment depression', 'MP:0011927', 'abnormal cardiac valve flow', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516880, 'HP:0031594', 'PR segment depression', 'MP:0013559', 'abnormal exocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516881, 'HP:0031594', 'PR segment depression', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516882, 'HP:0031594', 'PR segment depression', 'MP:0003549', 'pulmonary hypotension', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516883, 'HP:0031594', 'PR segment depression', 'MP:0001648', 'abnormal apoptosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516884, 'HP:0031594', 'PR segment depression', 'MP:0004149', 'increased bone strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516885, 'HP:0031594', 'PR segment depression', 'MP:0010511', 'shortened PR interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516886, 'HP:0031594', 'PR segment depression', 'MP:0010143', 'enhanced fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516887, 'HP:0031594', 'PR segment depression', 'MP:0001947', 'abnormal mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516888, 'HP:0031594', 'PR segment depression', 'MP:0006266', 'decreased pulse pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516889, 'HP:0031594', 'PR segment depression', 'MP:0020000', 'abnormal response to antigen', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516890, 'HP:0031594', 'PR segment depression', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516891, 'HP:0031594', 'PR segment depression', 'MP:0010950', 'abnormal lung hysteresivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516892, 'HP:0031594', 'PR segment depression', 'MP:0006051', 'brainstem hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516893, 'HP:0031594', 'PR segment depression', 'MP:0014274', 'decreased respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516894, 'HP:0031594', 'PR segment depression', 'MP:0003280', 'urinary incontinence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516895, 'HP:0031594', 'PR segment depression', 'MP:0013475', 'delayed reproductive senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516896, 'HP:0031594', 'PR segment depression', 'MP:0001876', 'decreased inflammatory response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516897, 'HP:0031594', 'PR segment depression', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516898, 'HP:0031594', 'PR segment depression', 'MP:0000313', 'abnormal cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516899, 'HP:0031594', 'PR segment depression', 'MP:0003901', 'abnormal PR interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516900, 'HP:0031594', 'PR segment depression', 'MP:0012006', 'abnormal hippocampus physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516901, 'HP:0031594', 'PR segment depression', 'MP:0004120', 'cardiac ischemia', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516902, 'HP:0031594', 'PR segment depression', 'MP:0004010', 'increased diastolic filling velocity', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516903, 'HP:0031594', 'PR segment depression', 'MP:0000231', 'hypertension', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516904, 'HP:0031594', 'PR segment depression', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516905, 'HP:0031594', 'PR segment depression', 'MP:0005333', 'decreased heart rate', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516906, 'HP:0031594', 'PR segment depression', 'MP:0005435', 'hemoperitoneum', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516907, 'HP:0031594', 'PR segment depression', 'MP:0031013', 'abnormal egg activation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516908, 'HP:0031594', 'PR segment depression', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516909, 'HP:0031594', 'PR segment depression', 'MP:0003298', 'choking', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516910, 'HP:0031594', 'PR segment depression', 'MP:0008272', 'abnormal endochondral bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516911, 'HP:0031594', 'PR segment depression', 'MP:0003038', 'decreased myocardial infarct size', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516912, 'HP:0031594', 'PR segment depression', 'MP:0010695', 'abnormal blood pressure regulation', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516913, 'HP:0031594', 'PR segment depression', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516914, 'HP:0031594', 'PR segment depression', 'MP:0004751', 'increased length of allograft survival', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516915, 'HP:0031594', 'PR segment depression', 'MP:0002106', 'abnormal muscle physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516916, 'HP:0031594', 'PR segment depression', 'MP:0004217', 'salt-sensitive hypertension', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516917, 'HP:0031594', 'PR segment depression', 'MP:0004046', 'abnormal mitosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516918, 'HP:0031594', 'PR segment depression', 'MP:0005076', 'abnormal cell differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516919, 'HP:0031594', 'PR segment depression', 'MP:0013134', 'poor circulation in autopods', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516920, 'HP:0031594', 'PR segment depression', 'MP:0011928', 'abnormal mitral valve flow', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516921, 'HP:0031594', 'PR segment depression', 'MP:0001915', 'intracranial hemorrhage', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516922, 'HP:0031594', 'PR segment depression', 'MP:0001790', 'abnormal immune system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516923, 'HP:0031594', 'PR segment depression', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516924, 'HP:0031594', 'PR segment depression', 'MP:0031089', 'sneezing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516925, 'HP:0031594', 'PR segment depression', 'MP:0009732', 'ventricular premature beat', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516926, 'HP:0031594', 'PR segment depression', 'MP:0031109', 'subarachnoid hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516927, 'HP:0031594', 'PR segment depression', 'MP:0010752', 'impaired mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516928, 'HP:0031594', 'PR segment depression', 'MP:0003233', 'prolonged QT interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516929, 'HP:0031594', 'PR segment depression', 'MP:0010680', 'abnormal skin adnexa physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516930, 'HP:0031594', 'PR segment depression', 'MP:0011954', 'shortened PQ interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516931, 'HP:0031594', 'PR segment depression', 'MP:0004782', 'abnormal surfactant physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516932, 'HP:0031594', 'PR segment depression', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516933, 'HP:0031594', 'PR segment depression', 'MP:0003393', 'decreased cardiac output', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516934, 'HP:0031594', 'PR segment depression', 'MP:0008006', 'increased stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516935, 'HP:0031594', 'PR segment depression', 'MP:0004156', 'abnormal QT variability', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516936, 'HP:0031594', 'PR segment depression', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516937, 'HP:0031594', 'PR segment depression', 'MP:0001664', 'abnormal digestion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516938, 'HP:0031594', 'PR segment depression', 'MP:0008817', 'hematoma', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516939, 'HP:0031594', 'PR segment depression', 'MP:0000738', 'impaired muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516940, 'HP:0031594', 'PR segment depression', 'MP:0030924', 'early exit from telogen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516941, 'HP:0031594', 'PR segment depression', 'MP:0003896', 'prolonged PR interval', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516942, 'HP:0031594', 'PR segment depression', 'MP:0002327', 'abnormal respiratory function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516943, 'HP:0031594', 'PR segment depression', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516944, 'HP:0031594', 'PR segment depression', 'MP:0006138', 'congestive heart failure', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516945, 'HP:0031594', 'PR segment depression', 'MP:0031102', 'rhinorrhea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516946, 'HP:0031594', 'PR segment depression', 'MP:0011951', 'increased cardiac stroke volume', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516947, 'HP:0031594', 'PR segment depression', 'MP:0010514', 'fragmented QRS complex', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516948, 'HP:0031594', 'PR segment depression', 'MP:0031128', 'cardiovascular shunt', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516949, 'HP:0031594', 'PR segment depression', 'MP:0006045', 'mitral valve regurgitation', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516950, 'HP:0031594', 'PR segment depression', 'MP:0011925', 'abnormal heart echocardiography feature', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516951, 'HP:0031594', 'PR segment depression', 'MP:0031153', 'stomach hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516952, 'HP:0031594', 'PR segment depression', 'MP:0002164', 'abnormal gland physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516953, 'HP:0031594', 'PR segment depression', 'MP:0002314', 'abnormal respiratory mechanics', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516954, 'HP:0031594', 'PR segment depression', 'MP:0003868', 'abnormal feces composition', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516955, 'HP:0031594', 'PR segment depression', 'MP:0008776', 'increased right ventricle peak pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516956, 'HP:0031594', 'PR segment depression', 'MP:0010637', 'sinus bradycardia', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516957, 'HP:0031594', 'PR segment depression', 'MP:0012111', 'failure of morula compaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516958, 'HP:0031594', 'PR segment depression', 'MP:0011399', 'increased endoneurial fluid pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516959, 'HP:0031594', 'PR segment depression', 'MP:0006054', 'spinal hemorrhage', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516960, 'HP:0031594', 'PR segment depression', 'MP:0010513', 'abnormal ventricular activation time', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516961, 'HP:0031594', 'PR segment depression', 'MP:0005005', 'abnormal self tolerance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516962, 'HP:0031594', 'PR segment depression', 'MP:0013561', 'abnormal endocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516963, 'HP:0031594', 'PR segment depression', 'MP:0000304', 'abnormal cardiac stroke volume', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516964, 'HP:0031594', 'PR segment depression', 'MP:0005025', 'abnormal response to infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516965, 'HP:0031594', 'PR segment depression', 'MP:0006112', 'angina', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516966, 'HP:0031594', 'PR segment depression', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516967, 'HP:0031594', 'PR segment depression', 'MP:0003463', 'abnormal single cell response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516968, 'HP:0031594', 'PR segment depression', 'MP:0000350', 'abnormal cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516969, 'HP:0031594', 'PR segment depression', 'MP:0002896', 'abnormal bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516970, 'HP:0031594', 'PR segment depression', 'MP:0003412', 'abnormal afterhyperpolarization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516971, 'HP:0031594', 'PR segment depression', 'MP:0008861', 'abnormal hair shedding', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516972, 'HP:0031594', 'PR segment depression', 'MP:0013806', 'encephalopathy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516973, 'HP:0031594', 'PR segment depression', 'MP:0001542', 'abnormal bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516974, 'HP:0031594', 'PR segment depression', 'MP:0002133', 'abnormal respiratory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516975, 'HP:0031594', 'PR segment depression', 'MP:0008775', 'abnormal heart ventricle pressure', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516976, 'HP:0031594', 'PR segment depression', 'MP:0009473', 'abnormal skin exfoliation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516977, 'HP:0031594', 'PR segment depression', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516978, 'HP:0031594', 'PR segment depression', 'MP:0031117', 'subdural hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516979, 'HP:0031594', 'PR segment depression', 'MP:0020846', 'abnormal cell motility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516980, 'HP:0031594', 'PR segment depression', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516981, 'HP:0031594', 'PR segment depression', 'MP:0031302', 'syncope', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516982, 'HP:0031594', 'PR segment depression', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516983, 'HP:0031594', 'PR segment depression', 'MP:0002419', 'abnormal innate immunity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516984, 'HP:0031594', 'PR segment depression', 'MP:0031091', 'hypogeusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516985, 'HP:0031594', 'PR segment depression', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516986, 'HP:0031594', 'PR segment depression', 'MP:0001596', 'hypotension', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516987, 'HP:0031594', 'PR segment depression', 'MP:0011022', 'abnormal circadian regulation of systemic arterial blood pressure', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516988, 'HP:0031594', 'PR segment depression', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516989, 'HP:0031594', 'PR segment depression', 'MP:0003900', 'shortened QT interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516990, 'HP:0031594', 'PR segment depression', 'MP:0005000', 'abnormal immune tolerance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516991, 'HP:0031594', 'PR segment depression', 'MP:0008005', 'decreased stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516992, 'HP:0031594', 'PR segment depression', 'MP:0006264', 'decreased systemic arterial systolic blood pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516993, 'HP:0031594', 'PR segment depression', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516994, 'HP:0031594', 'PR segment depression', 'MP:0001627', 'abnormal cardiac output', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516995, 'HP:0031594', 'PR segment depression', 'MP:0031088', 'coughing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516996, 'HP:0031594', 'PR segment depression', 'MP:0004086', 'absent heartbeat', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516997, 'HP:0031594', 'PR segment depression', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(516998, 'HP:0031594', 'PR segment depression', 'MP:0031092', 'dysgeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(516999, 'HP:0031594', 'PR segment depression', 'MP:0004945', 'abnormal bone resorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517000, 'HP:0031594', 'PR segment depression', 'MP:0008942', 'abnormal induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517001, 'HP:0031594', 'PR segment depression', 'MP:0002723', 'abnormal immune serum protein physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517002, 'HP:0031594', 'PR segment depression', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517003, 'HP:0031594', 'PR segment depression', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517004, 'HP:0031594', 'PR segment depression', 'MP:0001846', 'increased inflammatory response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517005, 'HP:0031594', 'PR segment depression', 'MP:0031130', 'right-to-left shunt', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517006, 'HP:0031594', 'PR segment depression', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517007, 'HP:0031594', 'PR segment depression', 'MP:0010507', 'shortened RR interval', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517008, 'HP:0031594', 'PR segment depression', 'MP:0010381', 'abnormal dosage compensation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517009, 'HP:0031594', 'PR segment depression', 'MP:0006044', 'tricuspid valve regurgitation', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517010, 'HP:0031594', 'PR segment depression', 'MP:0004142', 'abnormal muscle tone', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517011, 'HP:0031594', 'PR segment depression', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517012, 'HP:0031594', 'PR segment depression', 'MP:0010560', 'intraventricular block', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517013, 'HP:0031594', 'PR segment depression', 'MP:0005532', 'abnormal vascular resistance', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517014, 'HP:0031594', 'PR segment depression', 'MP:0001533', 'abnormal skeleton physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517015, 'HP:0031594', 'PR segment depression', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517016, 'HP:0031594', 'PR segment depression', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517017, 'HP:0031594', 'PR segment depression', 'MP:0012557', 'decreased calcium uptake by cardiac muscle', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517018, 'HP:0031594', 'PR segment depression', 'MP:0006109', 'fibrillation', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517019, 'HP:0031594', 'PR segment depression', 'MP:0003878', 'abnormal ear physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517020, 'HP:0031594', 'PR segment depression', 'MP:0005330', 'cardiomyopathy', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517021, 'HP:0031594', 'PR segment depression', 'MP:0020039', 'increased bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517022, 'HP:0031594', 'PR segment depression', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517023, 'HP:0031594', 'PR segment depression', 'MP:0006265', 'increased pulse pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517024, 'HP:0031594', 'PR segment depression', 'MP:0004213', 'abnormal umami taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517025, 'HP:0031594', 'PR segment depression', 'MP:0013640', 'increased bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517026, 'HP:0031594', 'PR segment depression', 'MP:0004484', 'abnormal response of heart to induced stress', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517027, 'HP:0031594', 'PR segment depression', 'MP:0004876', 'decreased mean systemic arterial blood pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517028, 'HP:0031594', 'PR segment depression', 'MP:0020346', 'abnormal myocardial fiber calcium currents', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517029, 'HP:0031594', 'PR segment depression', 'MP:0031170', 'abnormal vasculature physiology', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517030, 'HP:0031594', 'PR segment depression', 'MP:0001633', 'poor circulation', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517031, 'HP:0031594', 'PR segment depression', 'MP:0030951', 'abnormal endocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517032, 'HP:0031594', 'PR segment depression', 'MP:0004072', 'abnormal frontal plane axis', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517033, 'HP:0031594', 'PR segment depression', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517034, 'HP:0031594', 'PR segment depression', 'MP:0011929', 'abnormal aortic valve flow', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517035, 'HP:0031594', 'PR segment depression', 'MP:0005599', 'increased cardiac muscle contractility', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517036, 'HP:0031594', 'PR segment depression', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517037, 'HP:0031594', 'PR segment depression', 'MP:0003929', 'decreased heart rate variability', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517038, 'HP:0031594', 'PR segment depression', 'MP:0014037', 'stranguria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517039, 'HP:0031594', 'PR segment depression', 'MP:0001629', 'abnormal heart rate', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517040, 'HP:0031594', 'PR segment depression', 'MP:0000501', 'abnormal digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517041, 'HP:0031594', 'PR segment depression', 'MP:0002952', 'ventricular cardiomyopathy', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517042, 'HP:0031594', 'PR segment depression', 'MP:0010571', 'shortened ST segment', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517043, 'HP:0031594', 'PR segment depression', 'MP:0012045', 'increased susceptibility to hypertension', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517044, 'HP:0031594', 'PR segment depression', 'MP:0010504', 'abnormal RR interval', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517045, 'HP:0031594', 'PR segment depression', 'MP:0009562', 'abnormal odor adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517046, 'HP:0031594', 'PR segment depression', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517047, 'HP:0031594', 'PR segment depression', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517048, 'HP:0031594', 'PR segment depression', 'MP:0006047', 'aortic valve regurgitation', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517049, 'HP:0031594', 'PR segment depression', 'MP:0020345', 'abnormal myocardial fiber currents', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517050, 'HP:0031594', 'PR segment depression', 'MP:0002420', 'abnormal adaptive immunity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517051, 'HP:0031594', 'PR segment depression', 'MP:0002693', 'abnormal pancreas physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517052, 'HP:0031594', 'PR segment depression', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517053, 'HP:0031594', 'PR segment depression', 'MP:0004211', 'abnormal sour taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517054, 'HP:0031594', 'PR segment depression', 'MP:0031154', 'intestinal hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517055, 'HP:0031594', 'PR segment depression', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517056, 'HP:0031594', 'PR segment depression', 'MP:0001984', 'abnormal olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517057, 'HP:0031594', 'PR segment depression', 'MP:0003037', 'increased myocardial infarct size', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517058, 'HP:0031594', 'PR segment depression', 'MP:0000743', 'muscle spasm', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517059, 'HP:0031594', 'PR segment depression', 'MP:0003823', 'increased left ventricle developed pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517060, 'HP:0031594', 'PR segment depression', 'MP:0003633', 'abnormal nervous system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517061, 'HP:0031594', 'PR segment depression', 'MP:0031152', 'subcutaneous hemorrhage', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517062, 'HP:0031594', 'PR segment depression', 'MP:0004143', 'muscle hypertonia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517063, 'HP:0031594', 'PR segment depression', 'MP:0020096', 'high mean heart rate adaptation', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517064, 'HP:0031594', 'PR segment depression', 'MP:0003040', 'decreased time of peak ischemic contracture', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517065, 'HP:0031594', 'PR segment depression', 'MP:0004070', 'abnormal P wave', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517066, 'HP:0031594', 'PR segment depression', 'MP:0001800', 'abnormal humoral immune response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517067, 'HP:0031594', 'PR segment depression', 'MP:0003882', 'abnormal pulse pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517068, 'HP:0031594', 'PR segment depression', 'MP:0031169', 'abnormal joint physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517069, 'HP:0031594', 'PR segment depression', 'MP:0011930', 'abnormal tricuspid valve flow', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517070, 'HP:0031594', 'PR segment depression', 'MP:0008271', 'abnormal bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517071, 'HP:0031594', 'PR segment depression', 'MP:0012382', 'abnormal blood cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517072, 'HP:0031594', 'PR segment depression', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517073, 'HP:0031594', 'PR segment depression', 'MP:0010377', 'abnormal gut flora balance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517074, 'HP:0031594', 'PR segment depression', 'MP:0001756', 'abnormal urination', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517075, 'HP:0031594', 'PR segment depression', 'MP:0004145', 'abnormal muscle electrophysiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517076, 'HP:0031594', 'PR segment depression', 'MP:0003034', 'increased pulmonary vascular resistance', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517077, 'HP:0031594', 'PR segment depression', 'MP:0012046', 'decreased susceptibility to hypertension', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517078, 'HP:0031594', 'PR segment depression', 'MP:0003762', 'abnormal immune organ physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517079, 'HP:0031594', 'PR segment depression', 'MP:0000423', 'delayed hair regrowth', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517080, 'HP:0031594', 'PR segment depression', 'MP:0001835', 'abnormal antigen presentation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517081, 'HP:0031594', 'PR segment depression', 'MP:0010631', 'increased Q wave amplitude', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517082, 'HP:0031594', 'PR segment depression', 'MP:0010506', 'prolonged RR interval', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517083, 'HP:0031594', 'PR segment depression', 'MP:0020097', 'low mean heart rate adaptation', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517084, 'HP:0031594', 'PR segment depression', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517085, 'HP:0031594', 'PR segment depression', 'MP:0010510', 'absent P wave', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517086, 'HP:0031594', 'PR segment depression', 'MP:0002998', 'abnormal bone remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517087, 'HP:0031594', 'PR segment depression', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517088, 'HP:0031594', 'PR segment depression', 'MP:0006046', 'atrioventricular valve regurgitation', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517089, 'HP:0031594', 'PR segment depression', 'MP:0011919', 'abnormal R wave', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517090, 'HP:0031594', 'PR segment depression', 'MP:0010516', 'absent Q wave', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517091, 'HP:0031594', 'PR segment depression', 'MP:0000751', 'myopathy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517092, 'HP:0031594', 'PR segment depression', 'MP:0004071', 'prolonged P wave', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517093, 'HP:0031594', 'PR segment depression', 'MP:0031217', 'increased susceptibility to myocardial ischemic injury', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517094, 'HP:0031594', 'PR segment depression', 'MP:0011432', 'decreased urine flow rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517095, 'HP:0031594', 'PR segment depression', 'MP:0008950', 'ventricular tachycardia', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517096, 'HP:0031594', 'PR segment depression', 'MP:0003880', 'abnormal central pattern generator function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517097, 'HP:0031594', 'PR segment depression', 'MP:0004878', 'increased systemic vascular resistance', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517098, 'HP:0031594', 'PR segment depression', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517099, 'HP:0031594', 'PR segment depression', 'MP:0003259', 'nausea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517100, 'HP:0031594', 'PR segment depression', 'MP:0011514', 'skin hemorrhage', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517101, 'HP:0031594', 'PR segment depression', 'MP:0001598', 'abnormal blood viscosity', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517102, 'HP:0031594', 'PR segment depression', 'MP:0002498', 'abnormal acute inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517103, 'HP:0031594', 'PR segment depression', 'MP:0010758', 'increased right ventricle systolic pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517104, 'HP:0031594', 'PR segment depression', 'MP:0004215', 'abnormal myocardial fiber physiology', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517105, 'HP:0031594', 'PR segment depression', 'MP:0005410', 'abnormal fertilization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517106, 'HP:0031594', 'PR segment depression', 'MP:0009698', 'heart hemorrhage', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517107, 'HP:0031594', 'PR segment depression', 'MP:0006048', 'pulmonary valve regurgitation', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517108, 'HP:0031594', 'PR segment depression', 'MP:0010392', 'prolonged QRS complex duration', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517109, 'HP:0031594', 'PR segment depression', 'MP:0011952', 'decreased cardiac stroke volume', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517110, 'HP:0031594', 'PR segment depression', 'MP:0000465', 'gastrointestinal hemorrhage', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517111, 'HP:0031594', 'PR segment depression', 'MP:0011937', 'shortened PP interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517112, 'HP:0031594', 'PR segment depression', 'MP:0001916', 'intracerebral hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517113, 'HP:0031594', 'PR segment depression', 'MP:0020848', 'abnormal exocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517114, 'HP:0031594', 'PR segment depression', 'MP:0000249', 'abnormal blood vessel physiology', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517115, 'HP:0031594', 'PR segment depression', 'MP:0004994', 'abnormal brain wave pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517116, 'HP:0031594', 'PR segment depression', 'MP:0003438', 'abnormal carotid body physiology', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517117, 'HP:0031594', 'PR segment depression', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517118, 'HP:0031594', 'PR segment depression', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517119, 'HP:0031594', 'PR segment depression', 'MP:0002626', 'increased heart rate', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517120, 'HP:0031594', 'PR segment depression', 'MP:0005402', 'abnormal action potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517121, 'HP:0031594', 'PR segment depression', 'MP:0001924', 'infertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517122, 'HP:0031594', 'PR segment depression', 'MP:0003035', 'decreased pulmonary vascular resistance', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517123, 'HP:0031594', 'PR segment depression', 'MP:0020040', 'decreased bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517124, 'HP:0031594', 'PR segment depression', 'MP:0003041', 'increased time of onset of induced ischemic contracture', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517125, 'HP:0031594', 'PR segment depression', 'MP:0013127', 'epistaxis', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517126, 'HP:0031594', 'PR segment depression', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517127, 'HP:0031594', 'PR segment depression', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517128, 'HP:0031594', 'PR segment depression', 'MP:0011920', 'abnormal S wave', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517129, 'HP:0031594', 'PR segment depression', 'MP:0011047', 'increased lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517130, 'HP:0031594', 'PR segment depression', 'MP:0004486', 'decreased response of heart to induced stress', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517131, 'HP:0031594', 'PR segment depression', 'MP:0030909', 'abnormal melanocyte adhesion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517132, 'HP:0031594', 'PR segment depression', 'MP:0010505', 'abnormal T wave', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(517133, 'HP:0031594', 'PR segment depression', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517134, 'HP:0031594', 'PR segment depression', 'MP:0000316', 'cellular necrosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517135, 'HP:0031594', 'PR segment depression', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517136, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0009607', 'decreased keratohyalin granule size', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517137, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0008854', 'bleb', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517138, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0009604', 'increased keratohyalin granule number', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517139, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0001210', 'skin ridges', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517140, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0005501', 'abnormal skin physiology', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(517141, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0003853', 'dry skin', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517142, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0005421', 'loose skin', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517143, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0002163', 'abnormal gland morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(517144, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0014273', 'abnormal skin vasculature morphology', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517145, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0008816', 'petechiae', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517146, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0002060', 'abnormal skin morphology', 0.5416666666666666, 7.4735768925632104, 2.012010806002726, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517147, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0001216', 'abnormal epidermal layer morphology', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517148, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0001236', 'abnormal epidermis stratum spinosum morphology', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517149, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0001212', 'skin lesions', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517150, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0009606', 'increased keratohyalin granule size', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517151, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0001196', 'shiny skin', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517152, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0001243', 'abnormal dermal layer morphology', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517153, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0005499', 'abnormal olfactory system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(517154, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0012078', 'abnormal tail ring morphology', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517155, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0009932', 'skin fibrosis', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517156, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0013406', 'abnormal epidermal immune compartment', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517157, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0003940', 'abnormal dermatome morphology', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517158, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0011160', 'dermal-epidermal separation', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517159, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0010206', 'pigment incontinence', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517160, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0005174', 'abnormal tail pigmentation', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517161, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0001197', 'oily skin', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517162, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0005081', 'abnormal dermis reticular layer morphology', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517163, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0001201', 'translucent skin', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517164, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0003941', 'abnormal skin development', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517165, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0009385', 'abnormal dermal pigmentation', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517166, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(517167, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0001231', 'abnormal epidermis stratum basale morphology', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517168, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0009563', 'dyskeratosis', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517169, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0009602', 'abnormal keratohyalin granule morphology', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517170, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0009931', 'abnormal skin appearance', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517171, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0009610', 'abnormal epidermis stratum lucidum morphology', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517172, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0001195', 'flaky skin', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517173, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0001198', 'tight skin', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517174, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0001213', 'abnormal skin cell number', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517175, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0009379', 'abnormal foot pigmentation', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517176, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0009441', 'delayed skin barrier formation', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517177, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0005500', 'abnormal gustatory system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(517178, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0011159', 'abnormal epidermal-dermal junction morphology', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517179, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0008418', 'abnormal cutaneous elastic fiber morphology', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517180, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0001192', 'scaly skin', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517181, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0008856', 'fetal bleb', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517182, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0004241', 'acantholysis', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517183, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0001209', 'spontaneous skin ulceration', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517184, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0001230', 'epidermal desquamation', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517185, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0012248', 'absent dermatome', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517186, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(517187, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0002015', 'epithelioid cyst', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517188, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0003653', 'decreased skin turgor', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517189, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0010016', 'variable depigmentation', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517190, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0002897', 'blotchy skin', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517191, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0000367', 'abnormal coat/ hair morphology', 0.42857142857142855, 6.904974582545727, 1.7202542896592428, 'UPHENO:0003811', 'abnormal skin of body'),
(517192, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0009605', 'decreased keratohyalin granule number', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517193, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0003196', 'calcified skin', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517194, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0001233', 'abnormal epidermis suprabasal layer morphology', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517195, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0003717', 'pallor', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517196, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0001246', 'mixed cellular infiltration to dermis', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517197, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0002111', 'abnormal tail morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(517198, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0009545', 'abnormal dermis papillary layer morphology', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517199, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0001204', 'decreased sensitivity to skin irradiation', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517200, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0001193', 'psoriasis', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517201, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0009387', 'abnormal epidermal pigmentation', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517202, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0001191', 'abnormal skin condition', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517203, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0003385', 'abnormal body wall morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(517204, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0002095', 'abnormal skin pigmentation', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517205, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0011515', 'purpura', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517206, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0011239', 'abnormal skin coloration', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517207, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0008438', 'abnormal cutaneous collagen fibril morphology', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517208, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0009826', 'abnormal dermis reticular layer collagen network', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517209, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0009603', 'absent keratohyalin granules', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517210, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0010285', 'decreased skin tumor incidence', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517211, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0010232', 'delayed skin pigmentation appearance', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517212, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0008419', 'abnormal cutaneous microfibril morphology', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517213, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(517214, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0010678', 'abnormal skin adnexa morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(517215, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0003652', 'abnormal skin turgor', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517216, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0001239', 'abnormal epidermis stratum granulosum morphology', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517217, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0000574', 'abnormal foot pad morphology', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517218, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0010300', 'increased skin tumor incidence', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517219, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0031309', 'skin cyst', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517220, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0009827', 'skin detachment', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517221, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0001203', 'increased sensitivity to skin irradiation', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517222, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0001211', 'wrinkled skin', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517223, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0000377', 'abnormal hair follicle morphology', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517224, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0003705', 'abnormal hypodermis morphology', 0.4230769230769231, 6.509554027552121, 1.6595306832293713, 'UPHENO:0002635', 'abnormal integument'),
(517225, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0014134', 'abnormal embryo morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(517226, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0001202', 'skin photosensitivity', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517227, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0001208', 'blistering', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517228, 'HP:0007587', 'Numerous pigmented freckles', 'MP:0031103', 'skin rash', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(517229, 'HP:0002273', 'Tetraparesis', 'MP:0003202', 'abnormal neuron apoptosis', 0.4146341463414634, 11.437222266468964, 2.177673733821239, 'UPHENO:0085565', 'abnormality of neuron physiology'),
(517230, 'HP:0002273', 'Tetraparesis', 'MP:0009967', 'abnormal neuron proliferation', 0.425, 11.437222266468964, 2.2047266187101995, 'UPHENO:0085565', 'abnormality of neuron physiology'),
(517231, 'HP:0002273', 'Tetraparesis', 'MP:0004768', 'abnormal axonal transport', 0.4358974358974359, 11.437222266468964, 2.23281344042508, 'UPHENO:0085565', 'abnormality of neuron physiology'),
(517232, 'HP:0002273', 'Tetraparesis', 'MP:0004811', 'abnormal neuron physiology', 0.4473684210526316, 11.437222266468964, 2.2620017830625647, 'UPHENO:0085565', 'abnormality of neuron physiology'),
(517233, 'HP:0002273', 'Tetraparesis', 'MP:0021001', 'impaired neuron physiology', 0.4358974358974359, 11.437222266468964, 2.23281344042508, 'UPHENO:0085565', 'abnormality of neuron physiology'),
(517234, 'HP:0002273', 'Tetraparesis', 'MP:0004770', 'abnormal synaptic vesicle recycling', 0.4358974358974359, 11.437222266468964, 2.23281344042508, 'UPHENO:0085565', 'abnormality of neuron physiology'),
(517235, 'HP:0002273', 'Tetraparesis', 'MP:0011987', 'abnormal GABAergic neuron physiology', 0.4358974358974359, 11.437222266468964, 2.23281344042508, 'UPHENO:0085565', 'abnormality of neuron physiology'),
(517236, 'HP:0002273', 'Tetraparesis', 'MP:0010654', 'slow Wallerian degeneration', 0.40476190476190477, 11.437222266468964, 2.151592868030857, 'UPHENO:0085565', 'abnormality of neuron physiology'),
(517237, 'HP:0002273', 'Tetraparesis', 'MP:0010653', 'abnormal Wallerian degeneration', 0.4146341463414634, 11.437222266468964, 2.177673733821239, 'UPHENO:0085565', 'abnormality of neuron physiology'),
(517238, 'HP:0025503', 'Anomalous coronary artery arising from the opposite sinus', 'MP:0010477', 'coronary artery aneurysm', 0.40425531914893614, 12.607147267911277, 2.257544316806895, 'UPHENO:0076721', 'abnormal coronary artery morphology'),
(517239, 'HP:0025503', 'Anomalous coronary artery arising from the opposite sinus', 'MP:0004111', 'abnormal coronary artery morphology', 0.4222222222222222, 12.607147267911277, 2.3071666032907805, 'UPHENO:0076721', 'abnormal coronary artery morphology'),
(517240, 'HP:0025503', 'Anomalous coronary artery arising from the opposite sinus', 'MP:0011656', 'coronary arterio-venous fistula', 0.40425531914893614, 12.607147267911277, 2.257544316806895, 'UPHENO:0076721', 'abnormal coronary artery morphology'),
(517241, 'HP:0025503', 'Anomalous coronary artery arising from the opposite sinus', 'MP:0010476', 'coronary fistula', 0.41304347826086957, 12.607147267911277, 2.2819509106212372, 'UPHENO:0076721', 'abnormal coronary artery morphology'),
(517242, 'HP:0008007', 'Primary congenital glaucoma', 'MP:0006249', 'phthisis bulbi', 0.4032258064516129, 9.255471829629862, 1.9318501734328897, 'UPHENO:0072814', 'abnormally formed anatomical entity in independent continuant'),
(517243, 'HP:0008007', 'Primary congenital glaucoma', 'MP:0006248', 'lagophthalmos', 0.4032258064516129, 8.795504987450572, 1.883235139783118, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(517244, 'HP:0009485', 'Radial deviation of the hand or of fingers of the hand', 'MP:0031291', 'pes valgus', 0.43333333333333335, 6.296534486251748, 1.6518166597342931, 'UPHENO:0087006', 'abnormal autopod region morphology'),
(517245, 'HP:0009485', 'Radial deviation of the hand or of fingers of the hand', 'MP:0008909', 'supination', 0.43333333333333335, 6.296534486251748, 1.6518166597342931, 'UPHENO:0087006', 'abnormal autopod region morphology'),
(517246, 'HP:0009485', 'Radial deviation of the hand or of fingers of the hand', 'MP:0013133', 'pale limbs', 0.41379310344827586, 5.844765229200882, 1.5551602949913577, 'UPHENO:0086635', 'abnormal limb morphology'),
(517247, 'HP:0009485', 'Radial deviation of the hand or of fingers of the hand', 'MP:0000578', 'ulcerated paws', 0.43333333333333335, 6.296534486251748, 1.6518166597342931, 'UPHENO:0087006', 'abnormal autopod region morphology'),
(517248, 'HP:0009485', 'Radial deviation of the hand or of fingers of the hand', 'MP:0010772', 'abnormal pollex morphology', 0.45714285714285713, 7.243742537047754, 1.8197321670491124, 'UPHENO:0076723', 'abnormal manus morphology'),
(517249, 'HP:0009485', 'Radial deviation of the hand or of fingers of the hand', 'MP:0006279', 'abnormal limb development', 0.41379310344827586, 5.844765229200882, 1.5551602949913577, 'UPHENO:0086635', 'abnormal limb morphology'),
(517250, 'HP:0009485', 'Radial deviation of the hand or of fingers of the hand', 'MP:0002110', 'abnormal digit morphology', 0.40625, 6.296534486251748, 1.59936460353472, 'UPHENO:0087006', 'abnormal autopod region morphology'),
(517251, 'HP:0009485', 'Radial deviation of the hand or of fingers of the hand', 'MP:0000550', 'abnormal forelimb morphology', 0.4482758620689655, 6.940627358012219, 1.763892205383417, 'UPHENO:0086633', 'abnormal forelimb morphology'),
(517252, 'HP:0009485', 'Radial deviation of the hand or of fingers of the hand', 'MP:0003854', 'abnormal forelimb stylopod morphology', 0.4375, 7.310231061031986, 1.788358490124811, 'UPHENO:0002880', 'abnormal arm'),
(517253, 'HP:0009485', 'Radial deviation of the hand or of fingers of the hand', 'MP:0003855', 'abnormal forelimb zeugopod morphology', 0.45161290322580644, 7.310231061031986, 1.8169740429417593, 'UPHENO:0002880', 'abnormal arm'),
(517254, 'HP:0009485', 'Radial deviation of the hand or of fingers of the hand', 'MP:0000572', 'abnormal autopod morphology', 0.4482758620689655, 6.296534486251748, 1.6800548874579881, 'UPHENO:0087006', 'abnormal autopod region morphology'),
(517255, 'HP:0009485', 'Radial deviation of the hand or of fingers of the hand', 'MP:0002109', 'abnormal limb morphology', 0.42857142857142855, 5.844765229200882, 1.5826873929943446, 'UPHENO:0086635', 'abnormal limb morphology'),
(517256, 'HP:0009485', 'Radial deviation of the hand or of fingers of the hand', 'MP:0013076', 'autopod wound', 0.40625, 6.296534486251748, 1.59936460353472, 'UPHENO:0087006', 'abnormal autopod region morphology'),
(517257, 'HP:0011773', 'Uninodular goiter', 'MP:0001264', 'increased body size', 0.41025641025641024, 5.9605885577567275, 1.5637677783867745, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(517258, 'HP:0011773', 'Uninodular goiter', 'MP:0003493', 'parathyroid gland hyperplasia', 0.45454545454545453, 7.914822368502075, 1.896746301205648, 'UPHENO:0087376', 'abnormal endocrine gland morphology'),
(517259, 'HP:0011773', 'Uninodular goiter', 'MP:0004696', 'abnormal thyroid follicle morphology', 0.41025641025641024, 11.668547812575419, 2.187943449564563, 'UPHENO:0076716', 'abnormal thyroid gland morphology'),
(517260, 'HP:0011773', 'Uninodular goiter', 'MP:0031094', 'organomegaly', 0.4444444444444444, 5.9605885577567275, 1.6276211076642195, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(517261, 'HP:0011773', 'Uninodular goiter', 'MP:0020168', 'decreased thyroid gland weight', 0.425531914893617, 11.668547812575419, 2.228304174638854, 'UPHENO:0076716', 'abnormal thyroid gland morphology'),
(517262, 'HP:0011773', 'Uninodular goiter', 'MP:0008299', 'adrenal cortical hyperplasia', 0.4444444444444444, 7.914822368502075, 1.8755529399207496, 'UPHENO:0087376', 'abnormal endocrine gland morphology'),
(517263, 'HP:0011773', 'Uninodular goiter', 'MP:0008301', 'adrenal medulla hyperplasia', 0.43478260869565216, 7.914822368502075, 1.8550544781057057, 'UPHENO:0087376', 'abnormal endocrine gland morphology'),
(517264, 'HP:0011773', 'Uninodular goiter', 'MP:0002768', 'small adrenal glands', 0.4090909090909091, 7.914822368502075, 1.7994115365928876, 'UPHENO:0087376', 'abnormal endocrine gland morphology'),
(517265, 'HP:0011773', 'Uninodular goiter', 'MP:0003498', 'thyroid gland hyperplasia', 0.5609756097560976, 14.192109768632433, 2.8216001543776623, 'UPHENO:0001070', 'increased size of the thyroid gland'),
(517266, 'HP:0011773', 'Uninodular goiter', 'MP:0004661', 'absent thyroid parafollicular C-cells', 0.4186046511627907, 11.668547812575419, 2.2100923932404903, 'UPHENO:0076716', 'abnormal thyroid gland morphology'),
(517267, 'HP:0011773', 'Uninodular goiter', 'MP:0013937', 'absent lobe of thyroid gland', 0.42105263157894735, 11.668547812575419, 2.2165452314784035, 'UPHENO:0076716', 'abnormal thyroid gland morphology'),
(517268, 'HP:0011773', 'Uninodular goiter', 'MP:0013328', 'visceromegaly', 0.42105263157894735, 5.9605885577567275, 1.5842100548862934, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(517269, 'HP:0011773', 'Uninodular goiter', 'MP:0004698', 'abnormal thyroid parafollicular C-cell morphology', 0.42857142857142855, 11.668547812575419, 2.236248243238989, 'UPHENO:0076716', 'abnormal thyroid gland morphology'),
(517270, 'HP:0011773', 'Uninodular goiter', 'MP:0000642', 'enlarged adrenal glands', 0.47619047619047616, 7.914822368502075, 1.9413817328439134, 'UPHENO:0087376', 'abnormal endocrine gland morphology'),
(517271, 'HP:0011773', 'Uninodular goiter', 'MP:0008300', 'enlarged adrenal medulla', 0.46511627906976744, 7.914822368502075, 1.9186747326047344, 'UPHENO:0087376', 'abnormal endocrine gland morphology'),
(517272, 'HP:0011773', 'Uninodular goiter', 'MP:0000681', 'abnormal thyroid gland morphology', 0.43243243243243246, 11.668547812575419, 2.2462988477818633, 'UPHENO:0076716', 'abnormal thyroid gland morphology'),
(517273, 'HP:0011773', 'Uninodular goiter', 'MP:0009078', 'adrenal gland hyperplasia', 0.4444444444444444, 7.914822368502075, 1.8755529399207496, 'UPHENO:0087376', 'abnormal endocrine gland morphology'),
(517274, 'HP:0011773', 'Uninodular goiter', 'MP:0009171', 'enlarged pancreatic islets', 0.425531914893617, 7.914822368502075, 1.8352137528123316, 'UPHENO:0087376', 'abnormal endocrine gland morphology'),
(517275, 'HP:0011773', 'Uninodular goiter', 'MP:0005355', 'enlarged thyroid gland', 0.6052631578947368, 14.192109768632433, 2.930863554611714, 'UPHENO:0001070', 'increased size of the thyroid gland'),
(517276, 'HP:0011773', 'Uninodular goiter', 'MP:0003499', 'thyroid gland hypoplasia', 0.43478260869565216, 11.668547812575419, 2.2523946496210394, 'UPHENO:0076716', 'abnormal thyroid gland morphology'),
(517277, 'HP:0011773', 'Uninodular goiter', 'MP:0002951', 'small thyroid gland', 0.4878048780487805, 11.668547812575419, 2.3857859381595232, 'UPHENO:0076716', 'abnormal thyroid gland morphology'),
(517278, 'HP:0011773', 'Uninodular goiter', 'MP:0001267', 'enlarged chest', 0.41025641025641024, 5.9605885577567275, 1.5637677783867745, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(517279, 'HP:0011773', 'Uninodular goiter', 'MP:0003112', 'enlarged parathyroid gland', 0.4878048780487805, 7.914822368502075, 1.9649144918405266, 'UPHENO:0087376', 'abnormal endocrine gland morphology'),
(517280, 'HP:0011773', 'Uninodular goiter', 'MP:0013162', 'abnormal thyroid gland isthmus morphology', 0.41025641025641024, 11.668547812575419, 2.187943449564563, 'UPHENO:0076716', 'abnormal thyroid gland morphology'),
(517281, 'HP:0011773', 'Uninodular goiter', 'MP:0020169', 'increased thyroid gland weight', 0.5476190476190477, 14.192109768632433, 2.7878073167282342, 'UPHENO:0001070', 'increased size of the thyroid gland'),
(517282, 'HP:0011773', 'Uninodular goiter', 'MP:0003421', 'abnormal thyroid gland development', 0.41025641025641024, 11.668547812575419, 2.187943449564563, 'UPHENO:0076716', 'abnormal thyroid gland morphology'),
(517283, 'HP:0011773', 'Uninodular goiter', 'MP:0003113', 'small parathyroid gland', 0.4186046511627907, 7.914822368502075, 1.820214673213647, 'UPHENO:0087376', 'abnormal endocrine gland morphology'),
(517284, 'HP:0011773', 'Uninodular goiter', 'MP:0020145', 'enlarged adrenal gland x-zone', 0.4166666666666667, 7.914822368502075, 1.8159963253108558, 'UPHENO:0087376', 'abnormal endocrine gland morphology'),
(517285, 'HP:0011773', 'Uninodular goiter', 'MP:0004663', 'athyroidism', 0.42105263157894735, 11.668547812575419, 2.2165452314784035, 'UPHENO:0076716', 'abnormal thyroid gland morphology'),
(517286, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0031095', 'pharyngitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517287, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0011047', 'increased lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517288, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0001921', 'reduced fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517289, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0002128', 'abnormal blood circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517290, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0005596', 'increased susceptibility to type I hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517291, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517292, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0004947', 'skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517293, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517294, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0002420', 'abnormal adaptive immunity', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517295, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517296, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517297, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0031089', 'sneezing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517298, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008942', 'abnormal induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517299, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0003889', 'enhanced sensorimotor gating', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517300, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0002409', 'decreased susceptibility to infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517301, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0005088', 'increased acute inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517302, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0003746', 'stomatitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517303, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517304, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008705', 'increased interleukin-6 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517305, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0031009', 'abnormal sperm-egg fusion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517306, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0003633', 'abnormal nervous system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517307, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0002933', 'joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517308, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517309, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0001983', 'abnormal olfactory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517310, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517311, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0021016', 'decreased tau protein phosphorylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517312, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517313, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517314, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517315, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008681', 'increased interleukin-17 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517316, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0000751', 'myopathy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517317, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0031102', 'rhinorrhea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517318, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0010538', 'increased level of surface class II molecules', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517319, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008737', 'abnormal spleen physiology', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517320, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0005076', 'abnormal cell differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517321, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0030990', 'nerve inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517322, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0004143', 'muscle hypertonia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517323, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0031302', 'syncope', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517324, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0002473', 'impaired complement classical pathway', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517325, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0003777', 'lip inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517326, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0031110', 'meningitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517327, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0013636', 'abnormal bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517328, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517329, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517330, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517331, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0012565', 'perivasculitis', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517332, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0011764', 'ureteritis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517333, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0005620', 'abnormal muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517334, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0002161', 'abnormal fertility/fecundity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517335, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0001984', 'abnormal olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517336, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0001943', 'abnormal respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517337, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020000', 'abnormal response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517338, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020155', 'enhanced humoral immune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517339, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0005615', 'increased susceptibility to type III hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517340, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0005399', 'increased susceptibility to fungal infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517341, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517342, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0030153', 'dental pulp inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517343, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517344, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517345, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0003725', 'increased autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517346, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0001533', 'abnormal skeleton physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517347, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0005087', 'decreased acute inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517348, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008750', 'abnormal interferon level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517349, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517350, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008562', 'increased interferon-alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517351, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0031088', 'coughing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517352, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517353, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517354, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0002723', 'abnormal immune serum protein physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517355, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517356, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008568', 'abnormal interleukin secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517357, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0003762', 'abnormal immune organ physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517358, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0003009', 'abnormal cytokine secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517359, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0001837', 'defective assembly of class I molecules', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517360, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517361, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0005005', 'abnormal self tolerance', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517362, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0010822', 'pneumothorax', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517363, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0006082', 'CNS inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517364, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0013561', 'abnormal endocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517365, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020386', 'adipose tissue inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517366, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0010559', 'heart block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517367, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517368, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0009046', 'muscle twitch', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517369, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0014037', 'stranguria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517370, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020412', 'abnormal amnion physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517371, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0006080', 'brain ischemia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517372, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517373, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0003259', 'nausea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517374, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0031091', 'hypogeusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517375, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0004558', 'delayed allantois development', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517376, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0014274', 'decreased respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517377, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0003091', 'abnormal cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517378, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517379, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517380, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517381, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517382, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517383, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0013559', 'abnormal exocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517384, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517385, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0001663', 'abnormal digestive system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517386, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517387, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0010994', 'aerophagia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517388, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517389, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0002314', 'abnormal respiratory mechanics', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517390, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008565', 'decreased interferon-beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517391, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0011717', 'increased interleukin-8 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517392, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008682', 'decreased interleukin-17 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517393, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0009058', 'decreased interleukin-21 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517394, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008696', 'increased interleukin-3 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517395, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008005', 'decreased stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517396, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517397, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0006138', 'congestive heart failure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517398, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0006001', 'abnormal intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517399, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0001648', 'abnormal apoptosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517400, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517401, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008651', 'increased interleukin-1 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517402, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517403, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0002164', 'abnormal gland physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517404, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517405, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0003726', 'decreased autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517406, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517407, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0001933', 'abnormal litter size', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517408, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517409, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517410, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0003875', 'abnormal hair follicle regression', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517411, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517412, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517413, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0004145', 'abnormal muscle electrophysiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517414, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517415, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0005275', 'abnormal skin tensile strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517416, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0005410', 'abnormal fertilization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517417, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0010922', 'alveolitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517418, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517419, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517420, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517421, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008691', 'decreased interleukin-23 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517422, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0005363', 'decreased susceptibility to prion infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517423, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517424, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517425, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517426, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0002471', 'abnormal complement pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517427, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0031125', 'aspiration pneumonia', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517428, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517429, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517430, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0003280', 'urinary incontinence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517431, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0009562', 'abnormal odor adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517432, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517433, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517434, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008748', 'abnormal central T cell anergy', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517435, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0030129', 'tongue inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517436, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020002', 'increased response to antigen', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517437, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517438, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0012111', 'failure of morula compaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517439, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517440, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517441, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517442, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008721', 'abnormal chemokine level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517443, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0031223', 'increased CXCL10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517444, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517445, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517446, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517447, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020154', 'impaired humoral immune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517448, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0001846', 'increased inflammatory response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517449, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0003278', 'esophageal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517450, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0000313', 'abnormal cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517451, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0013942', 'enthesitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517452, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0004752', 'decreased length of allograft survival', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517453, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0002635', 'reduced sensorimotor gating', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517454, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517455, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0011762', 'renal/urinary system inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517456, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020096', 'high mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517457, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0004085', 'abnormal heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517458, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0011925', 'abnormal heart echocardiography feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517459, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008006', 'increased stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517460, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517461, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517462, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517463, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0000501', 'abnormal digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517464, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0000351', 'increased cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517465, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008699', 'increased interleukin-4 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517466, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008670', 'decreased interleukin-12b secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517467, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517468, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0002998', 'abnormal bone remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517469, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008558', 'abnormal interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517470, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0031128', 'cardiovascular shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517471, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008694', 'decreased interleukin-23a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517472, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0001876', 'decreased inflammatory response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517473, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517474, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008544', 'impaired olfaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517475, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0030924', 'early exit from telogen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517476, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0003927', 'increased cellular glucose import', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517477, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0004149', 'increased bone strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517478, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0001793', 'abnormal susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517479, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008652', 'decreased interleukin-1 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517480, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0001869', 'pancreas inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517481, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008697', 'decreased interleukin-3 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517482, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0003880', 'abnormal central pattern generator function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517483, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0010143', 'enhanced fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517484, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517485, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517486, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0002106', 'abnormal muscle physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517487, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517488, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0002500', 'granulomatous inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517489, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0010071', 'abnormal pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517490, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517491, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0001633', 'poor circulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517492, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008693', 'increased interleukin-23a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517493, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0005671', 'abnormal response to transplant', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517494, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0031054', 'bronchiolitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517495, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0012555', 'decreased cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517496, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0001841', 'decreased level of surface class I molecules', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517497, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517498, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0031055', 'bronchitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517499, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020040', 'decreased bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517500, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0003260', 'vomiting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517501, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008661', 'decreased interleukin-10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517502, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008684', 'increased interleukin-18 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517503, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0003868', 'abnormal feces composition', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517504, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008685', 'decreased interleukin-18 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517505, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0001849', 'ear inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517506, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517507, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0004751', 'increased length of allograft survival', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517508, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517509, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0011566', 'abnormal complement protein level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517510, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0031240', 'abnormal CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517511, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517512, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0030951', 'abnormal endocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517513, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517514, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0030987', 'spinal cord inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517515, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517516, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0003925', 'abnormal cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517517, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517518, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517519, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0010377', 'abnormal gut flora balance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517520, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0005532', 'abnormal vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517521, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0005617', 'increased susceptibility to type IV hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517522, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517523, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517524, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0010539', 'decreased level of surface class II molecules', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517525, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517526, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0005501', 'abnormal skin physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517527, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517528, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008751', 'abnormal interleukin level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517529, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517530, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517531, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0001627', 'abnormal cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517532, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0001867', 'rhinitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517533, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008687', 'increased interleukin-2 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517534, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0021015', 'increased tau protein phosphorylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517535, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0000423', 'delayed hair regrowth', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517536, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0004945', 'abnormal bone resorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517537, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0004212', 'abnormal salty taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517538, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517539, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008722', 'abnormal chemokine secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517540, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0001861', 'lung inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517541, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0005044', 'sepsis', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517542, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517543, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0001636', 'irregular heartbeat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517544, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517545, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517546, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0002421', 'abnormal cell-mediated immunity', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517547, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0001840', 'increased level of surface class I molecules', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517548, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008660', 'increased interleukin-10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517549, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008706', 'decreased interleukin-6 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517550, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008675', 'increased interleukin-15 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517551, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0031053', 'pleuritis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517552, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0003878', 'abnormal ear physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517553, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0004796', 'increased anti-histone antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517554, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0012685', 'abnormal primitive streak elongation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517555, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0011012', 'bronchiectasis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517556, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0010368', 'abnormal lymphatic system physiology', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517557, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517558, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517559, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0001872', 'sinus inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517560, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0031098', 'abnormal sputum production', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517561, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0011046', 'abnormal lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517562, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517563, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0010211', 'abnormal acute phase protein level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517564, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0001873', 'stomach inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517565, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020039', 'increased bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517566, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0011926', 'abnormal heart valve physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517567, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0009057', 'increased interleukin-21 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517568, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0002418', 'increased susceptibility to viral infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517569, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0012382', 'abnormal blood cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517570, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0003566', 'abnormal cell adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517571, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517572, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0011718', 'decreased interleukin-8 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517573, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0005042', 'abnormal level of surface class II molecules', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517574, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0001866', 'nasal inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517575, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008564', 'increased interferon-beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517576, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517577, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008666', 'increased interleukin-12a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517578, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517579, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517580, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0010950', 'abnormal lung hysteresivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517581, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0004046', 'abnormal mitosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517582, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0009062', 'impaired lectin complement pathway', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517583, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0001847', 'brain inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517584, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0001800', 'abnormal humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517585, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0004142', 'abnormal muscle tone', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517586, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0001790', 'abnormal immune system physiology', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517587, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0011432', 'decreased urine flow rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517588, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517589, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517590, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0005364', 'increased susceptibility to prion infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517591, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0003866', 'abnormal defecation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517592, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008702', 'increased interleukin-5 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517593, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517594, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0003470', 'abnormal summary potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517595, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0010381', 'abnormal dosage compensation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517596, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008747', 'abnormal T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517597, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008700', 'decreased interleukin-4 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517598, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0011082', 'abnormal gastrointestinal motility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517599, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517600, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0031169', 'abnormal joint physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517601, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0003767', 'palate inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517602, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517603, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517604, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0001756', 'abnormal urination', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517605, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0012553', 'decreased serum complement activity', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517606, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0003659', 'abnormal lymph circulation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517607, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0005597', 'decreased susceptibility to type I hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517608, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517609, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517610, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0013296', 'abnormal susceptibility to induced colitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517611, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0003674', 'oxidative stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517612, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0005043', 'defective assembly of class II molecules', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517613, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0001919', 'abnormal reproductive system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517614, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0030132', 'periodontium inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517615, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0010695', 'abnormal blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517616, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0010753', 'improved mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517617, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0004994', 'abnormal brain wave pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517618, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0005621', 'abnormal cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517619, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0001839', 'abnormal level of surface class I molecules', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517620, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0001947', 'abnormal mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517621, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0003621', 'dysuria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517622, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517623, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0000316', 'cellular necrosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517624, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008711', 'increased interleukin-9 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517625, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517626, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008555', 'abnormal interferon secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517627, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517628, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0001194', 'dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517629, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517630, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517631, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517632, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517633, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0000304', 'abnormal cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517634, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0011044', 'increased lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517635, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0000743', 'muscle spasm', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517636, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0001986', 'abnormal taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517637, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517638, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517639, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0013136', 'genital discharge', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517640, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0004213', 'abnormal umami taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517641, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517642, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0002322', 'abnormal respiratory transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517643, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517644, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008673', 'decreased interleukin-13 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517645, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0004829', 'increased anti-chromatin antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517646, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517647, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0031170', 'abnormal vasculature physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517648, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517649, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0013640', 'increased bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517650, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517651, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0004072', 'abnormal frontal plane axis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517652, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0003477', 'abnormal nerve fiber response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517653, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517654, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517655, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0014275', 'increased respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517656, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517657, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0030991', 'optic nerve inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517658, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0011399', 'increased endoneurial fluid pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517659, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0005025', 'abnormal response to infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517660, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517661, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0001985', 'abnormal gustatory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517662, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0001819', 'abnormal immune cell physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517663, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517664, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0012556', 'increased cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517665, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517666, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0031222', 'decreased CXCL10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517667, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0003186', 'abnormal redox activity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517668, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008664', 'decreased interleukin-12 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517669, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517670, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0003303', 'peritoneal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517671, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0010680', 'abnormal skin adnexa physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517672, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0014048', 'abnormal Peyers patch physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517673, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008563', 'decreased interferon-alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517674, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0011763', 'urethritis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517675, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008663', 'increased interleukin-12 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517676, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517677, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517678, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0002499', 'chronic inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517679, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0000427', 'abnormal hair cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517680, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0002419', 'abnormal innate immunity', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517681, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517682, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517683, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517684, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0011043', 'abnormal lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517685, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008672', 'increased interleukin-13 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517686, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517687, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0002896', 'abnormal bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517688, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0004782', 'abnormal surfactant physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517689, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0030214', 'muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517690, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020142', 'increased anti-sperm antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517691, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517692, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008744', 'abnormal B cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517693, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517694, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517695, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008676', 'decreased interleukin-15 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517696, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517697, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0013639', 'decreased bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517698, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0005402', 'abnormal action potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517699, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020001', 'decreased response to antigen', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517700, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008712', 'decreased interleukin-9 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517701, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0002406', 'increased susceptibility to infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517702, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517703, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0013475', 'delayed reproductive senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517704, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517705, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517706, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0030130', 'gum inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517707, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0002133', 'abnormal respiratory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517708, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0001629', 'abnormal heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517709, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0005613', 'increased susceptibility to type II hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517710, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517711, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0031066', 'cytokine storm', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517712, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008272', 'abnormal endochondral bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517713, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517714, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0000352', 'decreased cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517715, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020381', 'muscle gating pore current', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517716, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020097', 'low mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517717, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0002693', 'abnormal pancreas physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517718, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008861', 'abnormal hair shedding', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517719, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0005614', 'decreased susceptibility to type III hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517720, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0001864', 'vascular inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517721, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517722, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0004009', 'abnormal diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517723, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517724, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008690', 'increased interleukin-23 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517725, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517726, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0001950', 'abnormal respiratory sounds', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517727, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0001914', 'hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517728, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0005001', 'abnormal clonal deletion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517729, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517730, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517731, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0005616', 'decreased susceptibility to type IV hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517732, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0003463', 'abnormal single cell response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517733, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0003298', 'choking', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517734, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0031402', 'decreased muscle fatigability', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517735, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517736, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517737, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517738, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517739, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0003077', 'abnormal cell cycle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517740, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517741, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0031111', 'meningoencephalitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517742, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517743, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0011048', 'decreased lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517744, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517745, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0001542', 'abnormal bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517746, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0003926', 'decreased cellular glucose uptake', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517747, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517748, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020848', 'abnormal exocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517749, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0013971', 'blood in lymph vessels', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517750, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517751, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008198', 'abnormal follicular dendritic cell antigen presentation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517752, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0012554', 'increased serum complement activity', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517753, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517754, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0001761', 'abnormal urination pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517755, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0031092', 'dysgeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517756, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0004036', 'abnormal muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517757, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0005004', 'abnormal lymphocyte anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517758, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0005612', 'decreased susceptibility to type II hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517759, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0002498', 'abnormal acute inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517760, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0003865', 'lymph node inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517761, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0006114', 'cardiac murmur', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517762, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008679', 'decreased interleukin-16 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517763, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008567', 'decreased interferon-gamma secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517764, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0013806', 'encephalopathy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517765, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0002254', 'reproductive system inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517766, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0002472', 'impaired complement alternative pathway', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517767, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0001844', 'autoimmune response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517768, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0012006', 'abnormal hippocampus physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517769, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0010752', 'impaired mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517770, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008703', 'decreased interleukin-5 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517771, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517772, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008566', 'increased interferon-gamma secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517773, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517774, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517775, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0004211', 'abnormal sour taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517776, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008775', 'abnormal heart ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517777, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517778, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517779, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0005000', 'abnormal immune tolerance', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517780, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0004510', 'myositis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517781, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008004', 'abnormal stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517782, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0000738', 'impaired muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517783, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0003412', 'abnormal afterhyperpolarization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517784, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0005403', 'abnormal nerve conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517785, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008678', 'increased interleukin-16 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517786, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0002327', 'abnormal respiratory function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517787, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0001924', 'infertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517788, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0013498', 'trachea inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517789, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517790, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0001845', 'abnormal inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517791, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020371', 'abnormal glymphatic system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517792, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0009697', 'abnormal copulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517793, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0001835', 'abnormal antigen presentation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517794, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517795, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517796, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0011431', 'increased urine flow rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517797, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517798, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517799, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0003157', 'impaired muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517800, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0031221', 'abnormal CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517801, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517802, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0005666', 'abnormal adipose tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517803, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008271', 'abnormal bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517804, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008709', 'decreased interleukin-7 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517805, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0030988', 'dysosmia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517806, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0012573', 'decreased susceptibility to chemically induced skin inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517807, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020846', 'abnormal cell motility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517808, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0009473', 'abnormal skin exfoliation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517809, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0000350', 'abnormal cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517810, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008713', 'abnormal cytokine level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517811, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0002634', 'abnormal sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517812, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0002405', 'respiratory system inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517813, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517814, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0031013', 'abnormal egg activation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517815, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0031090', 'ageusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517816, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0030909', 'abnormal melanocyte adhesion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517817, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008667', 'decreased interleukin-12a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517818, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008708', 'increased interleukin-7 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517819, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0002410', 'decreased susceptibility to viral infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517820, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0004037', 'increased muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517821, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0001862', 'interstitial pneumonia', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517822, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0004512', 'anosmia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517823, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517824, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517825, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517826, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517827, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0011045', 'decreased lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517828, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517829, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517830, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517831, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517832, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008669', 'increased interleukin-12b secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517833, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0001664', 'abnormal digestion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517834, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517835, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517836, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0005190', 'osteomyelitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517837, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0008688', 'decreased interleukin-2 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(517838, 'HP:0034018', 'Anti-class II HLA antibody positivity', 'MP:0001666', 'abnormal intestinal absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(517839, 'HP:0032936', 'Intrusion symptom', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517840, 'HP:0032936', 'Intrusion symptom', 'MP:0003481', 'decreased nerve fiber response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517841, 'HP:0032936', 'Intrusion symptom', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517842, 'HP:0032936', 'Intrusion symptom', 'MP:0000948', 'nonconvulsive seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517843, 'HP:0032936', 'Intrusion symptom', 'MP:0008814', 'decreased nerve conduction velocity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517844, 'HP:0032936', 'Intrusion symptom', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517845, 'HP:0032936', 'Intrusion symptom', 'MP:0003474', 'abnormal summary potential intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517846, 'HP:0032936', 'Intrusion symptom', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517847, 'HP:0032936', 'Intrusion symptom', 'MP:0012011', 'febrile seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517848, 'HP:0032936', 'Intrusion symptom', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517849, 'HP:0032936', 'Intrusion symptom', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517850, 'HP:0032936', 'Intrusion symptom', 'MP:0003480', 'increased nerve fiber response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517851, 'HP:0032936', 'Intrusion symptom', 'MP:0003477', 'abnormal nerve fiber response', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517852, 'HP:0032936', 'Intrusion symptom', 'MP:0003482', 'increased nerve fiber response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517853, 'HP:0032936', 'Intrusion symptom', 'MP:0003483', 'decreased nerve fiber response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517854, 'HP:0032936', 'Intrusion symptom', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517855, 'HP:0032936', 'Intrusion symptom', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517856, 'HP:0032936', 'Intrusion symptom', 'MP:0003412', 'abnormal afterhyperpolarization', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517857, 'HP:0032936', 'Intrusion symptom', 'MP:0003471', 'abnormal summary potential threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517858, 'HP:0032936', 'Intrusion symptom', 'MP:0003472', 'increased summary potential threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517859, 'HP:0032936', 'Intrusion symptom', 'MP:0011994', 'increased nerve conduction velocity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517860, 'HP:0032936', 'Intrusion symptom', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517861, 'HP:0032936', 'Intrusion symptom', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517862, 'HP:0032936', 'Intrusion symptom', 'MP:0001752', 'abnormal hypothalamus secretion', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517863, 'HP:0032936', 'Intrusion symptom', 'MP:0001912', 'increased cerebrospinal fluid production', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517864, 'HP:0032936', 'Intrusion symptom', 'MP:0003467', 'abnormal single cell response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517865, 'HP:0032936', 'Intrusion symptom', 'MP:0002578', 'impaired ability to fire action potentials', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517866, 'HP:0032936', 'Intrusion symptom', 'MP:0011399', 'increased endoneurial fluid pressure', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517867, 'HP:0032936', 'Intrusion symptom', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517868, 'HP:0032936', 'Intrusion symptom', 'MP:0020371', 'abnormal glymphatic system physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517869, 'HP:0032936', 'Intrusion symptom', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517870, 'HP:0032936', 'Intrusion symptom', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517871, 'HP:0032936', 'Intrusion symptom', 'MP:0003476', 'decreased summary potential intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517872, 'HP:0032936', 'Intrusion symptom', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517873, 'HP:0032936', 'Intrusion symptom', 'MP:0005402', 'abnormal action potential', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517874, 'HP:0032936', 'Intrusion symptom', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517875, 'HP:0032936', 'Intrusion symptom', 'MP:0014120', 'focal seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517876, 'HP:0032936', 'Intrusion symptom', 'MP:0003475', 'increased summary potential intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517877, 'HP:0032936', 'Intrusion symptom', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517878, 'HP:0032936', 'Intrusion symptom', 'MP:0003463', 'abnormal single cell response', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517879, 'HP:0032936', 'Intrusion symptom', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517880, 'HP:0032936', 'Intrusion symptom', 'MP:0002635', 'reduced sensorimotor gating', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517881, 'HP:0032936', 'Intrusion symptom', 'MP:0021016', 'decreased tau protein phosphorylation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517882, 'HP:0032936', 'Intrusion symptom', 'MP:0012006', 'abnormal hippocampus physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517883, 'HP:0032936', 'Intrusion symptom', 'MP:0003465', 'increased single cell response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517884, 'HP:0032936', 'Intrusion symptom', 'MP:0003633', 'abnormal nervous system physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517885, 'HP:0032936', 'Intrusion symptom', 'MP:0005403', 'abnormal nerve conduction', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517886, 'HP:0032936', 'Intrusion symptom', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517887, 'HP:0032936', 'Intrusion symptom', 'MP:0002634', 'abnormal sensorimotor gating', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517888, 'HP:0032936', 'Intrusion symptom', 'MP:0003466', 'decreased single cell response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517889, 'HP:0032936', 'Intrusion symptom', 'MP:0021015', 'increased tau protein phosphorylation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517890, 'HP:0032936', 'Intrusion symptom', 'MP:0003880', 'abnormal central pattern generator function', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517891, 'HP:0032936', 'Intrusion symptom', 'MP:0000951', 'sporadic seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517892, 'HP:0032936', 'Intrusion symptom', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517893, 'HP:0032936', 'Intrusion symptom', 'MP:0005645', 'abnormal hypothalamus physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517894, 'HP:0032936', 'Intrusion symptom', 'MP:0003468', 'increased single cell response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517895, 'HP:0032936', 'Intrusion symptom', 'MP:0003470', 'abnormal summary potential', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517896, 'HP:0032936', 'Intrusion symptom', 'MP:0013806', 'encephalopathy', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517897, 'HP:0032936', 'Intrusion symptom', 'MP:0003469', 'decreased single cell response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517898, 'HP:0032936', 'Intrusion symptom', 'MP:0003889', 'enhanced sensorimotor gating', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517899, 'HP:0032936', 'Intrusion symptom', 'MP:0000947', 'convulsive seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517900, 'HP:0032936', 'Intrusion symptom', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517901, 'HP:0032936', 'Intrusion symptom', 'MP:0006080', 'brain ischemia', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517902, 'HP:0032936', 'Intrusion symptom', 'MP:0003473', 'decreased summary potential threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517903, 'HP:0032936', 'Intrusion symptom', 'MP:0003464', 'abnormal single cell response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517904, 'HP:0032936', 'Intrusion symptom', 'MP:0002064', 'seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517905, 'HP:0032936', 'Intrusion symptom', 'MP:0004994', 'abnormal brain wave pattern', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517906, 'HP:0032936', 'Intrusion symptom', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517907, 'HP:0032936', 'Intrusion symptom', 'MP:0021009', 'abnormal synaptic physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(517908, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0031274', 'increased susceptibility to induced aneurysm formation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517909, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0005499', 'abnormal olfactory system morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517910, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0003890', 'abnormal embryonic-extraembryonic boundary morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517911, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0013120', 'urogenital swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517912, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0010478', 'intracranial aneurysm', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517913, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0014137', 'abnormal preimplantation embryo morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517914, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0013113', 'greasy tail', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517915, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0003119', 'abnormal digestive system development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517916, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0000266', 'abnormal heart morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517917, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0000752', 'dystrophic muscle', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517918, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0011200', 'abnormal extraembryonic coelom morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517919, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0000003', 'abnormal adipose tissue morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517920, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0013124', 'mouth swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517921, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0010126', 'abnormal distal visceral endoderm morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517922, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0002164', 'abnormal gland physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517923, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0013283', 'failure of ventral body wall closure', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517924, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517925, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0010233', 'hairless tail', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517926, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0005457', 'abnormal percent body fat/body weight', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517927, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0011174', 'lipodystrophy', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517928, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0001718', 'abnormal visceral yolk sac morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517929, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0010678', 'abnormal skin adnexa morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517930, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0020981', 'abnormal immune system development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517931, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0006279', 'abnormal limb development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517932, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517933, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0013118', 'swellings', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517934, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0031377', 'ambiguous external genitalia', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517935, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517936, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0003384', 'abnormal ventral body wall morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517937, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0000685', 'abnormal immune system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517938, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0002925', 'abnormal cardiovascular development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517939, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0002210', 'abnormal sex determination', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517940, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0011199', 'abnormal amniotic cavity morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517941, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0003385', 'abnormal body wall morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517942, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0012514', 'pectus excavatum', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517943, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0000462', 'abnormal digestive system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517944, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0013123', 'head/neck swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517945, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0001983', 'abnormal olfactory system physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517946, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0002836', 'abnormal chorion morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517947, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0030572', 'abnormal pilosebaceous unit morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517948, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0031272', 'abnormal susceptibility to induced aneurysm formation', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517949, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0008923', 'thoracoschisis', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517950, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0013122', 'tail swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517951, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0010352', 'gastrointestinal tract polyps', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517952, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0031277', 'pectus carinatum', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517953, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517954, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0002132', 'abnormal respiratory system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517955, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517956, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0031310', 'abnormal cyst', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517957, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0000733', 'abnormal muscle development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517958, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0001985', 'abnormal gustatory system physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517959, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517960, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0002163', 'abnormal gland morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517961, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0002396', 'abnormal hematopoietic system morphology/development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517962, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0030222', 'hyperostosis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517963, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0010736', 'abnormal extraembryonic ectoderm morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517964, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0012260', 'encephalomeningocele', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517965, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0020973', 'abnormal gland development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517966, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0003936', 'abnormal reproductive system development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517967, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0014062', 'nervous system inclusion bodies', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517968, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0002160', 'abnormal reproductive system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517969, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0006281', 'abnormal tail development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517970, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0013133', 'pale limbs', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517971, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0000428', 'abnormal craniofacial morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517972, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0003861', 'abnormal nervous system development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517973, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0013121', 'testicular swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517974, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0003300', 'gastrointestinal ulcer', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517975, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0013558', 'abnormal exocrine gland morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517976, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0003115', 'abnormal respiratory system development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517977, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0013119', 'abdomen swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517978, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0003279', 'aneurysm', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517979, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0031099', 'abnormal sputum morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517980, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0003942', 'abnormal urinary system development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517981, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0031273', 'decreased susceptibility to induced aneurysm formation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517982, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0005029', 'abnormal amnion morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517983, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0004134', 'abnormal chest morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517984, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0002113', 'abnormal skeleton development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517985, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0012500', 'abnormal angioblastic cord morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517986, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0003795', 'abnormal bone structure', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517987, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0005500', 'abnormal gustatory system morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517988, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0005508', 'abnormal skeleton morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517989, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0013125', 'thorax swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517990, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0002111', 'abnormal tail morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517991, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0011167', 'abnormal adipose tissue development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517992, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0008533', 'abnormal anterior visceral endoderm morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517993, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0003632', 'abnormal nervous system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517994, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0000516', 'abnormal renal/urinary system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517995, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0020982', 'abnormal skin adnexa development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517996, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0013126', 'teat swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517997, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0001929', 'abnormal gametogenesis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517998, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0013332', 'peliosis', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(517999, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0014134', 'abnormal embryo morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(518000, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0002085', 'abnormal embryonic tissue morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(518001, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0013177', 'abnormal tail tip morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(518002, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0003935', 'abnormal craniofacial development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(518003, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0010680', 'abnormal skin adnexa physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(518004, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0001726', 'abnormal allantois morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(518005, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0014136', 'abnormal extraembryonic endoderm morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(518006, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0002108', 'abnormal muscle morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(518007, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0002109', 'abnormal limb morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(518008, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0011203', 'abnormal parietal yolk sac morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(518009, 'HP:0034058', 'Abnormal fetal morphology', 'MP:0005360', 'urolithiasis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(518010, 'HP:0012552', 'Increased neutrophil nuclear projections', 'MP:0005065', 'abnormal neutrophil morphology', 0.40625, 13.607147267911277, 2.3511494162619604, 'UPHENO:0088175', 'abnormal neutrophil morphology'),
(518011, 'HP:0012552', 'Increased neutrophil nuclear projections', 'MP:0008246', 'abnormal leukocyte morphology', 0.40384615384615385, 8.546451336223722, 1.8578082519913814, 'UPHENO:0085042', 'abnormal leukocyte morphology'),
(518012, 'HP:0012552', 'Increased neutrophil nuclear projections', 'MP:0008250', 'abnormal myeloid leukocyte morphology', 0.42592592592592593, 10.541058077453503, 2.1188935607713626, 'UPHENO:0085076', 'abnormal myeloid leukocyte morphology'),
(518013, 'HP:0012552', 'Increased neutrophil nuclear projections', 'MP:0008251', 'abnormal phagocyte morphology', 0.4107142857142857, 10.541058077453503, 2.0807121710977032, 'UPHENO:0085076', 'abnormal myeloid leukocyte morphology'),
(518014, 'HP:0025498', 'Aceruloplasminemia', 'MP:0031075', 'abnormal circulating troponin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518015, 'HP:0025498', 'Aceruloplasminemia', 'MP:0011971', 'increased circulating lactate dehydrogenase level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518016, 'HP:0025498', 'Aceruloplasminemia', 'MP:0021037', 'abnormal circulating orosomucoid 1 protein level', 0.42, 9.555485148088783, 2.003323179668545, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518017, 'HP:0025498', 'Aceruloplasminemia', 'MP:0002942', 'decreased circulating alanine transaminase level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518018, 'HP:0025498', 'Aceruloplasminemia', 'MP:0011894', 'decreased circulating transferrin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518019, 'HP:0025498', 'Aceruloplasminemia', 'MP:0031081', 'abnormal circulating D-dimer level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518020, 'HP:0025498', 'Aceruloplasminemia', 'MP:0011887', 'decreased circulating lipase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518021, 'HP:0025498', 'Aceruloplasminemia', 'MP:0005567', 'decreased circulating total protein level', 0.4375, 9.555485148088783, 2.0446331583657846, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518022, 'HP:0025498', 'Aceruloplasminemia', 'MP:0004700', 'abnormal circulating insulin-like growth factor I level', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(518023, 'HP:0025498', 'Aceruloplasminemia', 'MP:0020986', 'abnormal circulating ceruloplasmin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518024, 'HP:0025498', 'Aceruloplasminemia', 'MP:0031065', 'increased circulating procalcitonin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518025, 'HP:0025498', 'Aceruloplasminemia', 'MP:0031243', 'abnormal circulating CSF3 level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518026, 'HP:0025498', 'Aceruloplasminemia', 'MP:0031082', 'decreased circulating D-dimer level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518027, 'HP:0025498', 'Aceruloplasminemia', 'MP:0012622', 'increased circulating factor XIII level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518028, 'HP:0025498', 'Aceruloplasminemia', 'MP:0008588', 'abnormal circulating interleukin level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518029, 'HP:0025498', 'Aceruloplasminemia', 'MP:0012619', 'increased circulating factor X level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518030, 'HP:0025498', 'Aceruloplasminemia', 'MP:0031341', 'decreased circulating lipocalin 2 level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518031, 'HP:0025498', 'Aceruloplasminemia', 'MP:0013256', 'increased circulating thrombin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518032, 'HP:0025498', 'Aceruloplasminemia', 'MP:0031064', 'abnormal circulating procalcitonin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518033, 'HP:0025498', 'Aceruloplasminemia', 'MP:0010210', 'abnormal circulating cytokine level', 0.42, 9.555485148088783, 2.003323179668545, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518034, 'HP:0025498', 'Aceruloplasminemia', 'MP:0011895', 'abnormal circulating unsaturated transferrin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518035, 'HP:0025498', 'Aceruloplasminemia', 'MP:0030744', 'abnormal circulating homocitrulline level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(518036, 'HP:0025498', 'Aceruloplasminemia', 'MP:0020248', 'decreased circulating arginase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518037, 'HP:0025498', 'Aceruloplasminemia', 'MP:0020985', 'increased circulating factor XI level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518038, 'HP:0025498', 'Aceruloplasminemia', 'MP:0031165', 'increased circulating von Willebrand factor level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518039, 'HP:0025498', 'Aceruloplasminemia', 'MP:0030624', 'abnormal circulating cysteine level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(518040, 'HP:0025498', 'Aceruloplasminemia', 'MP:0011970', 'abnormal circulating lactate dehydrogenase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518041, 'HP:0025498', 'Aceruloplasminemia', 'MP:0012620', 'abnormal circulating factor XIII level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518042, 'HP:0025498', 'Aceruloplasminemia', 'MP:0008806', 'increased circulating amylase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518043, 'HP:0025498', 'Aceruloplasminemia', 'MP:0020247', 'increased circulating arginase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518044, 'HP:0025498', 'Aceruloplasminemia', 'MP:0011890', 'increased circulating ferritin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518045, 'HP:0025498', 'Aceruloplasminemia', 'MP:0031077', 'increased circulating troponin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518046, 'HP:0025498', 'Aceruloplasminemia', 'MP:0001570', 'abnormal circulating enzyme level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518047, 'HP:0025498', 'Aceruloplasminemia', 'MP:0000202', 'abnormal circulating alkaline phosphatase level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518048, 'HP:0025498', 'Aceruloplasminemia', 'MP:0031164', 'decreased circulating von Willebrand factor level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518049, 'HP:0025498', 'Aceruloplasminemia', 'MP:0010213', 'abnormal circulating fibrinogen level', 0.42, 9.555485148088783, 2.003323179668545, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518050, 'HP:0025498', 'Aceruloplasminemia', 'MP:0005416', 'abnormal circulating protein level', 0.5384615384615384, 9.555485148088783, 2.268316828308221, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518051, 'HP:0025498', 'Aceruloplasminemia', 'MP:0011897', 'decreased circulating unsaturated transferrin level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518052, 'HP:0025498', 'Aceruloplasminemia', 'MP:0013255', 'abnormal circulating thrombin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518053, 'HP:0025498', 'Aceruloplasminemia', 'MP:0011896', 'increased circulating unsaturated transferrin level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518054, 'HP:0025498', 'Aceruloplasminemia', 'MP:0001569', 'abnormal circulating bilirubin level', 0.4418604651162791, 8.001050554100775, 1.880252089283198, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(518055, 'HP:0025498', 'Aceruloplasminemia', 'MP:0012333', 'increased circulating fibronectin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518056, 'HP:0025498', 'Aceruloplasminemia', 'MP:0003349', 'abnormal circulating renin level', 0.45652173913043476, 9.555485148088783, 2.088608794877713, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518057, 'HP:0025498', 'Aceruloplasminemia', 'MP:0031114', 'increased circulating gamma-glutamyl transferase level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518058, 'HP:0025498', 'Aceruloplasminemia', 'MP:0030757', 'abnormal circulating histamine level', 0.4418604651162791, 8.001050554100775, 1.880252089283198, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(518059, 'HP:0025498', 'Aceruloplasminemia', 'MP:0012330', 'decreased circulating fibrinogen level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518060, 'HP:0025498', 'Aceruloplasminemia', 'MP:0011889', 'abnormal circulating ferritin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518061, 'HP:0025498', 'Aceruloplasminemia', 'MP:0006373', 'abnormal circulating angiotensinogen level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518062, 'HP:0025498', 'Aceruloplasminemia', 'MP:0031074', 'increased circulating type I collagen C-terminal telopeptide level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518063, 'HP:0025498', 'Aceruloplasminemia', 'MP:0001573', 'abnormal circulating alanine transaminase level', 0.45652173913043476, 9.555485148088783, 2.088608794877713, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518064, 'HP:0025498', 'Aceruloplasminemia', 'MP:0012327', 'abnormal circulating factor VIII level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518065, 'HP:0025498', 'Aceruloplasminemia', 'MP:0011893', 'increased circulating transferrin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518066, 'HP:0025498', 'Aceruloplasminemia', 'MP:0012328', 'decreased circulating factor VIII level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518067, 'HP:0025498', 'Aceruloplasminemia', 'MP:0030745', 'increased circulating homocitrulline level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(518068, 'HP:0025498', 'Aceruloplasminemia', 'MP:0031059', 'increased circulating C-reactive protein level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518069, 'HP:0025498', 'Aceruloplasminemia', 'MP:0012222', 'decreased circulating prothrombin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518070, 'HP:0025498', 'Aceruloplasminemia', 'MP:0011891', 'decreased circulating ferritin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518071, 'HP:0025498', 'Aceruloplasminemia', 'MP:0008820', 'abnormal blood uric acid level', 0.475, 8.001050554100775, 1.9494868589446475, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(518072, 'HP:0025498', 'Aceruloplasminemia', 'MP:0008804', 'abnormal circulating amylase level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518073, 'HP:0025498', 'Aceruloplasminemia', 'MP:0011972', 'decreased circulating lactate dehydrogenase level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518074, 'HP:0025498', 'Aceruloplasminemia', 'MP:0010333', 'abnormal circulating apolipoprotein E level', 0.42, 9.555485148088783, 2.003323179668545, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518075, 'HP:0025498', 'Aceruloplasminemia', 'MP:0005265', 'abnormal blood urea nitrogen level', 0.475, 8.001050554100775, 1.9494868589446475, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(518076, 'HP:0025498', 'Aceruloplasminemia', 'MP:0020217', 'increased circulating complement protein level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518077, 'HP:0025498', 'Aceruloplasminemia', 'MP:0012618', 'decreased circulating factor X level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518078, 'HP:0025498', 'Aceruloplasminemia', 'MP:0031083', 'increased circulating D-dimer level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518079, 'HP:0025498', 'Aceruloplasminemia', 'MP:0031060', 'decreased circulating C-reactive protein level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518080, 'HP:0025498', 'Aceruloplasminemia', 'MP:0012331', 'increased circulating fibrinogen level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518081, 'HP:0025498', 'Aceruloplasminemia', 'MP:0010091', 'decreased circulating creatine kinase level', 0.42, 9.555485148088783, 2.003323179668545, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518082, 'HP:0025498', 'Aceruloplasminemia', 'MP:0002965', 'increased circulating serum albumin level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518083, 'HP:0025498', 'Aceruloplasminemia', 'MP:0013403', 'abnormal circulating lactate level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(518084, 'HP:0025498', 'Aceruloplasminemia', 'MP:0012664', 'decreased circulating haptoglobin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518085, 'HP:0025498', 'Aceruloplasminemia', 'MP:0011284', 'abnormal circulating erythropoietin level', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(518086, 'HP:0025498', 'Aceruloplasminemia', 'MP:0031073', 'decreased circulating type I collagen C-terminal telopeptide level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518087, 'HP:0025498', 'Aceruloplasminemia', 'MP:0012326', 'increased circulating antithrombin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518088, 'HP:0025498', 'Aceruloplasminemia', 'MP:0031163', 'abnormal circulating von Willebrand factor level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518089, 'HP:0025498', 'Aceruloplasminemia', 'MP:0031079', 'increased circulating troponin I level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518090, 'HP:0025498', 'Aceruloplasminemia', 'MP:0012662', 'increased circulating ceruloplasmin level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518091, 'HP:0025498', 'Aceruloplasminemia', 'MP:0011912', 'abnormal circulating fibronectin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518092, 'HP:0025498', 'Aceruloplasminemia', 'MP:0031108', 'increased circulating myoglobin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518093, 'HP:0025498', 'Aceruloplasminemia', 'MP:0002695', 'abnormal circulating glucagon level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(518094, 'HP:0025498', 'Aceruloplasminemia', 'MP:0020984', 'decreased circulating factor XI level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518095, 'HP:0025498', 'Aceruloplasminemia', 'MP:0031107', 'abnormal circulating myoglobin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518096, 'HP:0025498', 'Aceruloplasminemia', 'MP:0012616', 'increased circulating factor IX level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518097, 'HP:0025498', 'Aceruloplasminemia', 'MP:0005308', 'abnormal circulating ammonia level', 0.4418604651162791, 8.001050554100775, 1.880252089283198, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(518098, 'HP:0025498', 'Aceruloplasminemia', 'MP:0005521', 'abnormal circulating atrial natriuretic factor level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(518099, 'HP:0025498', 'Aceruloplasminemia', 'MP:0011892', 'abnormal circulating transferrin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518100, 'HP:0025498', 'Aceruloplasminemia', 'MP:0011611', 'abnormal circulating ghrelin level', 0.4318181818181818, 8.001050554100775, 1.8587627882296205, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(518101, 'HP:0025498', 'Aceruloplasminemia', 'MP:0021035', 'decreased circulating cartilage oligomeric matrix protein level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518102, 'HP:0025498', 'Aceruloplasminemia', 'MP:0021034', 'abnormal circulating cartilage oligomeric matrix protein level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518103, 'HP:0025498', 'Aceruloplasminemia', 'MP:0021039', 'decreased circulating orosomucoid 1 protein level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518104, 'HP:0025498', 'Aceruloplasminemia', 'MP:0020246', 'abnormal circulating arginase level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518105, 'HP:0025498', 'Aceruloplasminemia', 'MP:0031072', 'abnormal circulating type I collagen C-terminal telopeptide level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518106, 'HP:0025498', 'Aceruloplasminemia', 'MP:0012614', 'abnormal circulating factor IX level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518107, 'HP:0025498', 'Aceruloplasminemia', 'MP:0008459', 'abnormal circulating pancreatic peptide level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(518108, 'HP:0025498', 'Aceruloplasminemia', 'MP:0002903', 'abnormal circulating parathyroid hormone level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(518109, 'HP:0025498', 'Aceruloplasminemia', 'MP:0010215', 'abnormal circulating complement protein level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518110, 'HP:0025498', 'Aceruloplasminemia', 'MP:0012221', 'abnormal circulating prothrombin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518111, 'HP:0025498', 'Aceruloplasminemia', 'MP:0011886', 'increased circulating lipase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518112, 'HP:0025498', 'Aceruloplasminemia', 'MP:0011888', 'abnormal circulating total protein level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518113, 'HP:0025498', 'Aceruloplasminemia', 'MP:0012329', 'increased circulating factor VIII level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518114, 'HP:0025498', 'Aceruloplasminemia', 'MP:0011008', 'abnormal circulating glutamate dehydrogenase level', 0.45652173913043476, 9.555485148088783, 2.088608794877713, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518115, 'HP:0025498', 'Aceruloplasminemia', 'MP:0013257', 'decreased circulating thrombin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518116, 'HP:0025498', 'Aceruloplasminemia', 'MP:0012223', 'increased circulating prothrombin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518117, 'HP:0025498', 'Aceruloplasminemia', 'MP:0008548', 'abnormal circulating interferon level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518118, 'HP:0025498', 'Aceruloplasminemia', 'MP:0002941', 'increased circulating alanine transaminase level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518119, 'HP:0025498', 'Aceruloplasminemia', 'MP:0020258', 'decreased circulating factor XII level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518120, 'HP:0025498', 'Aceruloplasminemia', 'MP:0012661', 'decreased circulating ceruloplasmin level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518121, 'HP:0025498', 'Aceruloplasminemia', 'MP:0012621', 'decreased circulating factor XIII level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518122, 'HP:0025498', 'Aceruloplasminemia', 'MP:0010212', 'abnormal circulating C-reactive protein level', 0.42, 9.555485148088783, 2.003323179668545, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518123, 'HP:0025498', 'Aceruloplasminemia', 'MP:0020983', 'abnormal circulating factor XI level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518124, 'HP:0025498', 'Aceruloplasminemia', 'MP:0020256', 'abnormal circulating factor XII level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518125, 'HP:0025498', 'Aceruloplasminemia', 'MP:0005419', 'decreased circulating serum albumin level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518126, 'HP:0025498', 'Aceruloplasminemia', 'MP:0010330', 'abnormal circulating lipoprotein level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(518127, 'HP:0025498', 'Aceruloplasminemia', 'MP:0010106', 'abnormal circulating pyruvate kinase level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518128, 'HP:0025498', 'Aceruloplasminemia', 'MP:0008805', 'decreased circulating amylase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518129, 'HP:0025498', 'Aceruloplasminemia', 'MP:0021036', 'increased circulating cartilage oligomeric matrix protein level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518130, 'HP:0025498', 'Aceruloplasminemia', 'MP:0020341', 'abnormal circulating hyaluronic acid level', 0.4418604651162791, 8.001050554100775, 1.880252089283198, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(518131, 'HP:0025498', 'Aceruloplasminemia', 'MP:0012666', 'increased circulating haptoglobin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518132, 'HP:0025498', 'Aceruloplasminemia', 'MP:0031234', 'increased circulating serum amyloid protein level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518133, 'HP:0025498', 'Aceruloplasminemia', 'MP:0012325', 'decreased circulating antithrombin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518134, 'HP:0025498', 'Aceruloplasminemia', 'MP:0012332', 'decreased circulating fibronectin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518135, 'HP:0025498', 'Aceruloplasminemia', 'MP:0001560', 'abnormal circulating insulin level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(518136, 'HP:0025498', 'Aceruloplasminemia', 'MP:0010209', 'abnormal circulating chemokine level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518137, 'HP:0025498', 'Aceruloplasminemia', 'MP:0010089', 'abnormal circulating creatine kinase level', 0.45652173913043476, 9.555485148088783, 2.088608794877713, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518138, 'HP:0025498', 'Aceruloplasminemia', 'MP:0020216', 'decreased circulating complement protein level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518139, 'HP:0025498', 'Aceruloplasminemia', 'MP:0020257', 'increased circulating factor XII level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518140, 'HP:0025498', 'Aceruloplasminemia', 'MP:0020255', 'absent circulating factor XII protein', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518141, 'HP:0025498', 'Aceruloplasminemia', 'MP:0000199', 'abnormal circulating serum albumin level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518142, 'HP:0025498', 'Aceruloplasminemia', 'MP:0012617', 'abnormal circulating factor X level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518143, 'HP:0025498', 'Aceruloplasminemia', 'MP:0005311', 'abnormal circulating amino acid level', 0.4318181818181818, 8.001050554100775, 1.8587627882296205, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(518144, 'HP:0025498', 'Aceruloplasminemia', 'MP:0010216', 'abnormal circulating retinol binding protein level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518145, 'HP:0025498', 'Aceruloplasminemia', 'MP:0010090', 'increased circulating creatine kinase level', 0.42, 9.555485148088783, 2.003323179668545, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518146, 'HP:0025498', 'Aceruloplasminemia', 'MP:0000203', 'abnormal circulating aspartate transaminase level', 0.45652173913043476, 9.555485148088783, 2.088608794877713, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518147, 'HP:0025498', 'Aceruloplasminemia', 'MP:0010332', 'abnormal circulating apolipoprotein level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518148, 'HP:0025498', 'Aceruloplasminemia', 'MP:0010214', 'abnormal circulating serum amyloid protein level', 0.42, 9.555485148088783, 2.003323179668545, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518149, 'HP:0025498', 'Aceruloplasminemia', 'MP:0031233', 'decreased circulating serum amyloid protein level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518150, 'HP:0025498', 'Aceruloplasminemia', 'MP:0012615', 'decreased circulating factor IX level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518151, 'HP:0025498', 'Aceruloplasminemia', 'MP:0031078', 'increased circulating troponin T level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518152, 'HP:0025498', 'Aceruloplasminemia', 'MP:0009699', 'hyperchylomicronemia', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(518153, 'HP:0025498', 'Aceruloplasminemia', 'MP:0031340', 'abnormal circulating lipocalin 2 level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518154, 'HP:0025498', 'Aceruloplasminemia', 'MP:0031342', 'increased circulating lipocalin 2 level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518155, 'HP:0025498', 'Aceruloplasminemia', 'MP:0005667', 'abnormal circulating leptin level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(518156, 'HP:0025498', 'Aceruloplasminemia', 'MP:0004730', 'abnormal circulating gastrin level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(518157, 'HP:0025498', 'Aceruloplasminemia', 'MP:0012324', 'abnormal circulating antithrombin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518158, 'HP:0025498', 'Aceruloplasminemia', 'MP:0031076', 'decreased circulating troponin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518159, 'HP:0025498', 'Aceruloplasminemia', 'MP:0021038', 'increased circulating orosomucoid 1 protein level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518160, 'HP:0025498', 'Aceruloplasminemia', 'MP:0005632', 'decreased circulating aspartate transaminase level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518161, 'HP:0025498', 'Aceruloplasminemia', 'MP:0000188', 'abnormal circulating glucose level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(518162, 'HP:0025498', 'Aceruloplasminemia', 'MP:0011885', 'abnormal circulating lipase level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(518163, 'HP:0007657', 'Diffuse nuclear cataract', 'MP:0010251', 'subcapsular cataract', 0.4444444444444444, 12.214829845132515, 2.3299813871581336, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(518164, 'HP:0007657', 'Diffuse nuclear cataract', 'MP:0001304', 'cataract', 0.4528301886792453, 12.214829845132515, 2.351859626647865, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(518165, 'HP:0007657', 'Diffuse nuclear cataract', 'MP:0010255', 'cortical cataract', 0.4444444444444444, 12.214829845132515, 2.3299813871581336, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(518166, 'HP:0007657', 'Diffuse nuclear cataract', 'MP:0010261', 'sutural cataract', 0.43636363636363634, 12.214829845132515, 2.308702572611963, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(518167, 'HP:0007657', 'Diffuse nuclear cataract', 'MP:0010253', 'posterior subcapsular cataract', 0.43636363636363634, 12.214829845132515, 2.308702572611963, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(518168, 'HP:0007657', 'Diffuse nuclear cataract', 'MP:0010258', 'polar cataract', 0.4444444444444444, 12.214829845132515, 2.3299813871581336, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(518169, 'HP:0007657', 'Diffuse nuclear cataract', 'MP:0006209', 'calcified intraocular region', 0.41509433962264153, 8.581084971325078, 1.887315500762381, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(518170, 'HP:0007657', 'Diffuse nuclear cataract', 'MP:0031317', 'spherophakia', 0.41379310344827586, 10.410750055107773, 2.0755472951796, 'UPHENO:0087578', 'abnormal lens of camera-type eye morphology'),
(518171, 'HP:0007657', 'Diffuse nuclear cataract', 'MP:0001303', 'abnormal lens morphology', 0.40384615384615385, 10.410750055107773, 2.0504490650608487, 'UPHENO:0087578', 'abnormal lens of camera-type eye morphology'),
(518172, 'HP:0007657', 'Diffuse nuclear cataract', 'MP:0001306', 'small lens', 0.42105263157894735, 10.410750055107773, 2.093674689968286, 'UPHENO:0087578', 'abnormal lens of camera-type eye morphology'),
(518173, 'HP:0007657', 'Diffuse nuclear cataract', 'MP:0010254', 'nuclear cataract', 0.4444444444444444, 12.214829845132515, 2.3299813871581336, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(518174, 'HP:0007657', 'Diffuse nuclear cataract', 'MP:0010257', 'posterior cortical cataract', 0.43636363636363634, 12.214829845132515, 2.308702572611963, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(518175, 'HP:0007657', 'Diffuse nuclear cataract', 'MP:0013732', 'mature cataract', 0.4444444444444444, 12.214829845132515, 2.3299813871581336, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(518176, 'HP:0007657', 'Diffuse nuclear cataract', 'MP:0008841', 'ruptured lens capsule', 0.42105263157894735, 10.410750055107773, 2.093674689968286, 'UPHENO:0087578', 'abnormal lens of camera-type eye morphology'),
(518177, 'HP:0007657', 'Diffuse nuclear cataract', 'MP:0031345', 'developmental cataract', 0.4444444444444444, 12.214829845132515, 2.3299813871581336, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(518178, 'HP:0007657', 'Diffuse nuclear cataract', 'MP:0010256', 'anterior cortical cataract', 0.43636363636363634, 12.214829845132515, 2.308702572611963, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(518179, 'HP:0007657', 'Diffuse nuclear cataract', 'MP:0013731', 'immature cataract', 0.4444444444444444, 12.214829845132515, 2.3299813871581336, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(518180, 'HP:0007657', 'Diffuse nuclear cataract', 'MP:0010260', 'posterior polar cataract', 0.43636363636363634, 12.214829845132515, 2.308702572611963, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(518181, 'HP:0007657', 'Diffuse nuclear cataract', 'MP:0006225', 'ocular rupture', 0.41509433962264153, 8.581084971325078, 1.887315500762381, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(518182, 'HP:0007657', 'Diffuse nuclear cataract', 'MP:0010252', 'anterior subcapsular cataract', 0.43636363636363634, 12.214829845132515, 2.308702572611963, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(518183, 'HP:0007657', 'Diffuse nuclear cataract', 'MP:0010259', 'anterior polar cataract', 0.43636363636363634, 12.214829845132515, 2.308702572611963, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(518184, 'HP:0007657', 'Diffuse nuclear cataract', 'MP:0010262', 'lamellar cataract', 0.4444444444444444, 12.214829845132515, 2.3299813871581336, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(518185, 'HP:0007657', 'Diffuse nuclear cataract', 'MP:0002697', 'abnormal eye size', 0.41509433962264153, 8.581084971325078, 1.887315500762381, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(518186, 'HP:0007657', 'Diffuse nuclear cataract', 'MP:0010263', 'total cataract', 0.4444444444444444, 12.214829845132515, 2.3299813871581336, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(518187, 'HP:0007657', 'Diffuse nuclear cataract', 'MP:0001305', 'enlarged lens', 0.42105263157894735, 10.410750055107773, 2.093674689968286, 'UPHENO:0087578', 'abnormal lens of camera-type eye morphology'),
(518188, 'HP:0500022', 'Abnormal circulating dehydroepiandrosterone concentration', 'MP:0005183', 'abnormal circulating estradiol level', 0.45098039215686275, 10.169741955603977, 2.1415775062491624, 'UPHENO:0076293', 'abnormal hormone blood level'),
(518189, 'HP:0500022', 'Abnormal circulating dehydroepiandrosterone concentration', 'MP:0005180', 'abnormal circulating testosterone level', 0.4807692307692308, 12.982656403003482, 2.4983317898576267, 'UPHENO:0076290', 'abnormal androgen blood level'),
(518190, 'HP:0500022', 'Abnormal circulating dehydroepiandrosterone concentration', 'MP:0005184', 'abnormal circulating progesterone level', 0.45098039215686275, 10.169741955603977, 2.1415775062491624, 'UPHENO:0076293', 'abnormal hormone blood level'),
(518191, 'HP:0500022', 'Abnormal circulating dehydroepiandrosterone concentration', 'MP:0000180', 'abnormal circulating cholesterol level', 0.40384615384615385, 9.93472192593978, 2.0030225259147323, 'UPHENO:0051628', 'abnormal blood lipid level'),
(518192, 'HP:0500022', 'Abnormal circulating dehydroepiandrosterone concentration', 'MP:0014162', 'decreased circulating cortisol level', 0.43137254901960786, 10.169741955603977, 2.094504120373254, 'UPHENO:0076293', 'abnormal hormone blood level'),
(518193, 'HP:0500022', 'Abnormal circulating dehydroepiandrosterone concentration', 'MP:0014160', 'abnormal circulating cortisol level', 0.44, 10.169741955603977, 2.11534547071294, 'UPHENO:0076293', 'abnormal hormone blood level'),
(518194, 'HP:0500022', 'Abnormal circulating dehydroepiandrosterone concentration', 'MP:0003366', 'abnormal circulating glucocorticoid level', 0.4489795918367347, 10.169741955603977, 2.1368216098476704, 'UPHENO:0076293', 'abnormal hormone blood level'),
(518195, 'HP:0500022', 'Abnormal circulating dehydroepiandrosterone concentration', 'MP:0005346', 'abnormal circulating aldosterone level', 0.4230769230769231, 10.169741955603977, 2.074266890991422, 'UPHENO:0076293', 'abnormal hormone blood level'),
(518196, 'HP:0500022', 'Abnormal circulating dehydroepiandrosterone concentration', 'MP:0011973', 'abnormal circulating glycerol level', 0.42, 9.93472192593978, 2.042690189161026, 'UPHENO:0051628', 'abnormal blood lipid level'),
(518197, 'HP:0500022', 'Abnormal circulating dehydroepiandrosterone concentration', 'MP:0011611', 'abnormal circulating ghrelin level', 0.4166666666666667, 10.169741955603977, 2.0584927693586046, 'UPHENO:0076293', 'abnormal hormone blood level'),
(518198, 'HP:0500022', 'Abnormal circulating dehydroepiandrosterone concentration', 'MP:0003508', 'abnormal circulating dihydrotestosterone level', 0.5, 12.982656403003482, 2.5478085095826453, 'UPHENO:0076290', 'abnormal androgen blood level'),
(518199, 'HP:0500022', 'Abnormal circulating dehydroepiandrosterone concentration', 'MP:0003457', 'abnormal circulating ketone body level', 0.44680851063829785, 9.93472192593978, 2.1068740606250755, 'UPHENO:0051628', 'abnormal blood lipid level'),
(518200, 'HP:0500022', 'Abnormal circulating dehydroepiandrosterone concentration', 'MP:0003372', 'abnormal circulating mineralocorticoid level', 0.4489795918367347, 10.169741955603977, 2.1368216098476704, 'UPHENO:0076293', 'abnormal hormone blood level'),
(518201, 'HP:0500022', 'Abnormal circulating dehydroepiandrosterone concentration', 'MP:0005345', 'abnormal circulating corticosterone level', 0.42592592592592593, 10.169741955603977, 2.0812392363369376, 'UPHENO:0076293', 'abnormal hormone blood level'),
(518202, 'HP:0500022', 'Abnormal circulating dehydroepiandrosterone concentration', 'MP:0014161', 'increased circulating cortisol level', 0.43137254901960786, 10.169741955603977, 2.094504120373254, 'UPHENO:0076293', 'abnormal hormone blood level'),
(518203, 'HP:0010075', 'Duplication of the 1st metatarsal', 'MP:0030827', 'femur fracture', 0.4084507042253521, 7.694257931681313, 1.7727732710887576, 'UPHENO:0079871', 'abnormal anatomical entity morphology in the skeleton of pelvic complex'),
(518204, 'HP:0010075', 'Duplication of the 1st metatarsal', 'MP:0004641', 'elongated metatarsal bones', 0.43243243243243246, 11.548253578857707, 2.2346899976175627, 'UPHENO:0020817', 'abnormal metatarsal bone morphology'),
(518205, 'HP:0010075', 'Duplication of the 1st metatarsal', 'MP:0004635', 'short metatarsal bones', 0.43243243243243246, 11.548253578857707, 2.2346899976175627, 'UPHENO:0020817', 'abnormal metatarsal bone morphology'),
(518206, 'HP:0010075', 'Duplication of the 1st metatarsal', 'MP:0004642', 'fused metatarsal bones', 0.43243243243243246, 11.548253578857707, 2.2346899976175627, 'UPHENO:0020817', 'abnormal metatarsal bone morphology'),
(518207, 'HP:0010075', 'Duplication of the 1st metatarsal', 'MP:0030823', 'increased femur size', 0.4027777777777778, 7.694257931681313, 1.7604192998747883, 'UPHENO:0079871', 'abnormal anatomical entity morphology in the skeleton of pelvic complex'),
(518208, 'HP:0010075', 'Duplication of the 1st metatarsal', 'MP:0030825', 'decreased femur size', 0.4027777777777778, 7.694257931681313, 1.7604192998747883, 'UPHENO:0079871', 'abnormal anatomical entity morphology in the skeleton of pelvic complex'),
(518209, 'HP:0001805', 'Onychogryposis', 'MP:0012401', 'long nails', 0.4225352112676056, 11.192109768632431, 2.174640307181704, 'UPHENO:0088109', 'abnormal nail morphology'),
(518210, 'HP:0001805', 'Onychogryposis', 'MP:0000583', 'long toenails', 0.40540540540540543, 11.192109768632431, 2.1301037059481938, 'UPHENO:0088109', 'abnormal nail morphology'),
(518211, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008776', 'increased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518212, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0031424', 'enhanced female fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518213, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0031402', 'decreased muscle fatigability', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518214, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0005617', 'increased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518215, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0001837', 'defective assembly of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518216, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008006', 'increased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518217, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0031104', 'crackles', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518218, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518219, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518220, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518221, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0031051', 'lymph node hemorrhage', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518222, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518223, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0014274', 'decreased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518224, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518225, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0004994', 'abnormal brain wave pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518226, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0000743', 'muscle spasm', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518227, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0005501', 'abnormal skin physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518228, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0010071', 'abnormal pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518229, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0012120', 'trophectoderm cell degeneration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518230, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0030214', 'muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518231, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020940', 'increased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518232, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0001963', 'abnormal hearing physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518233, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008775', 'abnormal heart ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518234, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0013627', 'increased vertebra yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518235, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0001629', 'abnormal heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518236, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518237, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518238, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0012565', 'perivasculitis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518239, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008705', 'increased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518240, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0013135', 'poor circulation in tail', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518241, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518242, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0011012', 'bronchiectasis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518243, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0031130', 'right-to-left shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518244, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0031066', 'cytokine storm', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518245, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518246, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0005580', 'periinsulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518247, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008699', 'increased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518248, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518249, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518250, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008651', 'increased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518251, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0003157', 'impaired muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518252, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0013559', 'abnormal exocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518253, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518254, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0013752', 'stridor', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518255, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0003009', 'abnormal cytokine secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518256, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0004829', 'increased anti-chromatin antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518257, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0031088', 'coughing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518258, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518259, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518260, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0004752', 'decreased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518261, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008817', 'hematoma', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518262, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518263, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0001914', 'hemorrhage', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518264, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518265, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0003777', 'lip inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518266, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0014030', 'abnormal mucous gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518267, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0002254', 'reproductive system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518268, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0004877', 'abnormal systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518269, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0001666', 'abnormal intestinal absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518270, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0003079', 'decreased susceptibility to induced joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518271, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518272, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0000751', 'myopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518273, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518274, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008568', 'abnormal interleukin secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518275, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518276, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008272', 'abnormal endochondral bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518277, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0012608', 'abnormal complement C5 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518278, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0001853', 'heart inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518279, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518280, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0000313', 'abnormal cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518281, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0009643', 'abnormal urine homeostasis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518282, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008685', 'decreased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518283, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518284, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0003878', 'abnormal ear physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518285, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0013638', 'decreased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518286, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0009046', 'muscle twitch', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518287, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0010560', 'intraventricular block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518288, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0005001', 'abnormal clonal deletion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518289, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0000738', 'impaired muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518290, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518291, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0000343', 'abnormal response to cardiac infarction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518292, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0005253', 'abnormal eye physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518293, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0031126', 'gangrene', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518294, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0031241', 'decreased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518295, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518296, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518297, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0005004', 'abnormal lymphocyte anergy', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518298, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518299, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0004145', 'abnormal muscle electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518300, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518301, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0012197', 'impaired myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518302, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0010994', 'aerophagia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518303, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008563', 'decreased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518304, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0009384', 'cardiac valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518305, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518306, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008663', 'increased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518307, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0002405', 'respiratory system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518308, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518309, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518310, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518311, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0005000', 'abnormal immune tolerance', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518312, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518313, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008681', 'increased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518314, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0004512', 'anosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518315, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0004149', 'increased bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518316, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0010680', 'abnormal skin adnexa physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518317, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0013640', 'increased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518318, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518319, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518320, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0011431', 'increased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518321, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008722', 'abnormal chemokine secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518322, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020925', 'increased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518323, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008737', 'abnormal spleen physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518324, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518325, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0003122', 'maternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518326, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008260', 'abnormal autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518327, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0003889', 'enhanced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518328, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0004036', 'abnormal muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518329, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0000505', 'decreased digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518330, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020040', 'decreased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518331, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0004122', 'abnormal sinus arrhythmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518332, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0006001', 'abnormal intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518333, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0004761', 'increased susceptibility to induced pancreatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518334, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0002406', 'increased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518335, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518336, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0010504', 'abnormal RR interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518337, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0031111', 'meningoencephalitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518338, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518339, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518340, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008721', 'abnormal chemokine level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518341, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518342, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0006082', 'CNS inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518343, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518344, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0002410', 'decreased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518345, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0003659', 'abnormal lymph circulation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518346, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518347, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0001634', 'internal hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518348, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0010695', 'abnormal blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518349, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518350, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0004011', 'decreased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518351, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0010538', 'increased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518352, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0000501', 'abnormal digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518353, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518354, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518355, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518356, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0031086', 'wheezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518357, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0000304', 'abnormal cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518358, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0011046', 'abnormal lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518359, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518360, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518361, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0011048', 'decreased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518362, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0013641', 'increased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518363, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008694', 'decreased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518364, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0030990', 'nerve inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518365, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518366, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0002473', 'impaired complement classical pathway', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518367, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0010954', 'abnormal cellular respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518368, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0031224', 'abnormal CXCL10 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518369, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0011082', 'abnormal gastrointestinal motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518370, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0000740', 'impaired smooth muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518371, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0001849', 'ear inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518372, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0031240', 'abnormal CSF3 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518373, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0011013', 'bronchiolectasis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518374, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008672', 'increased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518375, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0001919', 'abnormal reproductive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518376, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518377, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518378, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0010752', 'impaired mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518379, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008001', 'hypochlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518380, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0011717', 'increased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518381, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0003875', 'abnormal hair follicle regression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518382, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0011927', 'abnormal cardiac valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518383, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0002314', 'abnormal respiratory mechanics', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518384, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518385, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518386, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020943', 'increased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518387, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0031169', 'abnormal joint physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518388, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518389, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0003477', 'abnormal nerve fiber response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518390, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0003699', 'abnormal female reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518391, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0002419', 'abnormal innate immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518392, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518393, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0001790', 'abnormal immune system physiology', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518394, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0011918', 'abnormal PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518395, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0004072', 'abnormal frontal plane axis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518396, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0005671', 'abnormal response to transplant', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518397, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020155', 'enhanced humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518398, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0003454', 'erythroderma', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518399, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0013136', 'genital discharge', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518400, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518401, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0005363', 'decreased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518402, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0031221', 'abnormal CXCL10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518403, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518404, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0002500', 'granulomatous inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518405, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0031425', 'enhanced male fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518406, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0013639', 'decreased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518407, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008004', 'abnormal stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518408, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0003470', 'abnormal summary potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518409, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0003698', 'abnormal male reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518410, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518411, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0010559', 'heart block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518412, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0001636', 'irregular heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518413, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0030132', 'periodontium inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518414, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0031170', 'abnormal vasculature physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518415, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0013555', 'abnormal apocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518416, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0003762', 'abnormal immune organ physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518417, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0011951', 'increased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518418, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0001858', 'intestinal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518419, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518420, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518421, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0031125', 'aspiration pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518422, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518423, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0004085', 'abnormal heartbeat', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518424, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518425, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0011044', 'increased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518426, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0013459', 'perioral dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518427, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0005190', 'osteomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518428, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0002418', 'increased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518429, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0011952', 'decreased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518430, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0009057', 'increased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518431, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020414', 'abnormal fibroblast physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518432, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008664', 'decreased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518433, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020154', 'impaired humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518434, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518435, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0004211', 'abnormal sour taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518436, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0004212', 'abnormal salty taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518437, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0010922', 'alveolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518438, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0013806', 'encephalopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518439, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518440, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008708', 'increased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518441, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0011764', 'ureteritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518442, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0002993', 'arthritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518443, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008684', 'increased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518444, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518445, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518446, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518447, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518448, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518449, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518450, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518451, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0011699', 'abnormal brown adipose tissue thermogenesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518452, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020938', 'decreased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518453, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008713', 'abnormal cytokine level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518454, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008709', 'decreased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518455, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518456, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0010539', 'decreased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518457, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518458, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0021015', 'increased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518459, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008002', 'hyperchlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518460, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0013634', 'increased femur fracture load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518461, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518462, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518463, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0011045', 'decreased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518464, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008673', 'decreased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518465, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518466, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518467, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0009058', 'decreased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518468, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020934', 'increased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518469, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518470, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0001947', 'abnormal mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518471, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0010505', 'abnormal T wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518472, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518473, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518474, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0010758', 'increased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518475, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008007', 'abnormal cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518476, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0001950', 'abnormal respiratory sounds', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518477, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518478, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0030822', 'sacroiliac joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518479, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0003280', 'urinary incontinence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518480, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0031013', 'abnormal egg activation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518481, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0011566', 'abnormal complement protein level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518482, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0001533', 'abnormal skeleton physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518483, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0005036', 'diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518484, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0005044', 'sepsis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518485, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0002420', 'abnormal adaptive immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518486, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518487, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0031246', 'abnormal CCL3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518488, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0011194', 'abnormal hair follicle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518489, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518490, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0001756', 'abnormal urination', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518491, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0001793', 'abnormal susceptibility to infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518492, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0031053', 'pleuritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518493, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518494, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0009732', 'ventricular premature beat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518495, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518496, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0004010', 'increased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518497, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0012111', 'failure of morula compaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518498, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518499, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518500, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0002421', 'abnormal cell-mediated immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518501, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0002896', 'abnormal bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518502, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0031128', 'cardiovascular shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518503, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518504, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0002064', 'seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518505, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518506, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0002472', 'impaired complement alternative pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518507, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0011920', 'abnormal S wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518508, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0031469', 'abnormal pinocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518509, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0002998', 'abnormal bone remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518510, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008679', 'decreased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518511, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008751', 'abnormal interleukin level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518512, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518513, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0003866', 'abnormal defecation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518514, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0005042', 'abnormal level of surface class II molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518515, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020935', 'decreased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518516, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518517, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0011926', 'abnormal heart valve physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518518, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020381', 'muscle gating pore current', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518519, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0031054', 'bronchiolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518520, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518521, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0031223', 'increased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518522, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0001873', 'stomach inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518523, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518524, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518525, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518526, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0002327', 'abnormal respiratory function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518527, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020926', 'decreased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518528, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008943', 'increased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518529, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008696', 'increased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518530, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518531, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0002694', 'abnormal pancreas secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518532, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008660', 'increased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518533, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0012556', 'increased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518534, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0001627', 'abnormal cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518535, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518536, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0003927', 'increased cellular glucose import', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518537, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0013498', 'trachea inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518538, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0005532', 'abnormal vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518539, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518540, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0011994', 'increased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518541, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0003898', 'abnormal QRS complex', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518542, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0001983', 'abnormal olfactory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518543, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0010368', 'abnormal lymphatic system physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518544, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0013475', 'delayed reproductive senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518545, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020848', 'abnormal exocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518546, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0003261', 'hematemesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518547, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518548, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0000316', 'cellular necrosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518549, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0011043', 'abnormal lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518550, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518551, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0001924', 'infertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518552, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518553, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518554, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0031092', 'dysgeusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518555, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0001633', 'poor circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518556, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0011805', 'decreased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518557, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020147', 'abnormal defecation amount', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518558, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0005621', 'abnormal cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518559, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020953', 'decreased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518560, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0000503', 'excessive digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518561, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0003633', 'abnormal nervous system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518562, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0011763', 'urethritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518563, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0003186', 'abnormal redox activity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518564, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0002693', 'abnormal pancreas physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518565, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518566, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0001985', 'abnormal gustatory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518567, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0003077', 'abnormal cell cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518568, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0003725', 'increased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518569, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008564', 'increased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518570, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518571, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008942', 'abnormal induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518572, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518573, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020097', 'low mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518574, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0004781', 'abnormal surfactant composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518575, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020845', 'abnormal DNA-templated transcription', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518576, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518577, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518578, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0000350', 'abnormal cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518579, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518580, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020846', 'abnormal cell motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518581, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518582, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008670', 'decreased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518583, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0011518', 'abnormal cell chemotaxis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518584, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0006002', 'abnormal small intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518585, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0013644', 'increased vertebra maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518586, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0012555', 'decreased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518587, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518588, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0004760', 'increased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518589, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0013561', 'abnormal endocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518590, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0002471', 'abnormal complement pathway', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518591, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008687', 'increased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518592, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518593, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518594, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518595, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0012382', 'abnormal blood cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518596, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0003897', 'abnormal ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518597, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518598, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518599, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020371', 'abnormal glymphatic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518600, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0001542', 'abnormal bone strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518601, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518602, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0005402', 'abnormal action potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518603, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0003123', 'paternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518604, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518605, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0003393', 'decreased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518606, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0001867', 'rhinitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518607, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020002', 'increased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518608, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008666', 'increased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518609, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020941', 'decreased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518610, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008003', 'achlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518611, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518612, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0013296', 'abnormal susceptibility to induced colitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518613, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0006138', 'congestive heart failure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518614, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0004759', 'decreased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518615, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008747', 'abnormal T cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518616, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008682', 'decreased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518617, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008691', 'decreased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518618, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518619, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518620, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0010072', 'increased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518621, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008562', 'increased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518622, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0013557', 'abnormal merocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518623, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0010552', 'abnormal HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518624, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518625, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518626, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0003298', 'choking', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518627, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008703', 'decreased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518628, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008652', 'decreased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518629, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020937', 'increased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518630, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518631, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518632, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020949', 'increased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518633, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0003880', 'abnormal central pattern generator function', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518634, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518635, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008814', 'decreased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518636, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518637, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518638, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008271', 'abnormal bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518639, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0001872', 'sinus inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518640, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0001945', 'bronchoconstriction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518641, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0003926', 'decreased cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518642, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518643, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0002322', 'abnormal respiratory transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518644, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0001761', 'abnormal urination pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518645, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518646, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518647, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518648, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0011047', 'increased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518649, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0001851', 'eye inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518650, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518651, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0003467', 'abnormal single cell response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518652, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0001986', 'abnormal taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518653, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020944', 'decreased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518654, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518655, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518656, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0031095', 'pharyngitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518657, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518658, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518659, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518660, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518661, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020001', 'decreased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518662, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0005005', 'abnormal self tolerance', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518663, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518664, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518665, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008661', 'decreased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518666, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0013637', 'increased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518667, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020386', 'adipose tissue inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518668, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0031105', 'rhonchi', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518669, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0003547', 'abnormal pulmonary pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518670, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0001663', 'abnormal digestive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518671, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0002296', 'aspiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518672, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0005615', 'increased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518673, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0010155', 'abnormal intestine physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518674, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008700', 'decreased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518675, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0001835', 'abnormal antigen presentation', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518676, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518677, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0001648', 'abnormal apoptosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518678, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0001839', 'abnormal level of surface class I molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518679, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008750', 'abnormal interferon level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518680, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0005275', 'abnormal skin tensile strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518681, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518682, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518683, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0010143', 'enhanced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518684, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0004009', 'abnormal diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518685, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0031110', 'meningitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518686, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008706', 'decreased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518687, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0013556', 'abnormal holocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518688, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020950', 'decreased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518689, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020142', 'increased anti-sperm antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518690, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0004031', 'insulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518691, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518692, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020096', 'high mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518693, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518694, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0005043', 'defective assembly of class II molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518695, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0001664', 'abnormal digestion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518696, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0004046', 'abnormal mitosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518697, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0030991', 'optic nerve inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518698, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518699, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0004782', 'abnormal surfactant physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518700, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518701, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0013642', 'decreased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518702, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518703, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0013625', 'increased femur yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518704, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518705, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0005088', 'increased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518706, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0000423', 'delayed hair regrowth', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518707, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518708, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0003674', 'oxidative stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518709, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518710, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0001921', 'reduced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518711, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518712, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008688', 'decreased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518713, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0003726', 'decreased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518714, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0001844', 'autoimmune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518715, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0030129', 'tongue inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518716, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518717, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518718, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518719, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008675', 'increased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518720, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0004751', 'increased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518721, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0001866', 'nasal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518722, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0001984', 'abnormal olfaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518723, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0031102', 'rhinorrhea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518724, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0013632', 'increased femur maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518725, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0002933', 'joint inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518726, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518727, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0006003', 'abnormal large intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518728, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008565', 'decreased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518729, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518730, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0000351', 'increased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518731, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0010753', 'improved mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518732, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0006114', 'cardiac murmur', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518733, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518734, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518735, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518736, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0002626', 'increased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518737, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0001862', 'interstitial pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518738, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0011809', 'abnormal anoikis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518739, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518740, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0003882', 'abnormal pulse pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518741, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0010756', 'decreased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518742, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0005596', 'increased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518743, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0008702', 'increased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518744, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518745, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518746, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0031089', 'sneezing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518747, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0005614', 'decreased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518748, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0005087', 'decreased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518749, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0002161', 'abnormal fertility/fecundity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518750, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0001840', 'increased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(518751, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0010073', 'decreased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518752, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0009045', 'muscle tetany', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(518753, 'HP:0034104', 'Anti-neutrophil elastase antibody positivity', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
